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ABSTRACT

DESIGN AND TESTING OF A PUMPLESS MICROELECTROMECHANICAL SYSTEM NANOINJECTOR

Quentin T. Aten
Department of Mechanical Engineering
Master of Science

A deeper understanding of human development and disease is made possible partly
through the study of genetically modified model organisms, such as the common mouse
(Mus musculus). By genetically modifying such model organisms, scientists can activate,
deactivate, or highlight particular characteristics. A genetically modified animal is generated by adding exogenous (foreign) genetic material to one or more embryonic cells at
their earliest stages of development. Frequently, this exogenous genetic material consists
of specially engineered DNA, which is introduced into a fertilized egg cell (zygote). When
successfully introduced into the zygote, the exogenous DNA will be incorporated into the
cell’s own genome, and the animal that develops from the zygote will exhibit the genetic
modification in all of its cells.
The current devices and methods for generating genetically modified animals are
inefficient, and/or difficult to use. The most common and efficient method for inserting
new DNA into zygotes is by directly injecting a DNA solution through a tiny glass tube
into the cell in a process called microinjection. Unfortunately, microinjection is quite inef-

ficient (success rates are commonly between 1 and 5%), but often it is the only method for
inserting DNA into eggs, zygotes, or early stage embryos.
This thesis presents the design and testing of a micrometer sale, pumpless microelectromechanical system (MEMS) nanoinjector. Rather than use pumps and capillaries,
the nanoinjector employs electrostatic charges to attract and repel DNA onto and off of
the surface of a solid lance. The nanoinjector also includes a mechanical system for constraining the target cells during injection. Initial testing indicates the nanoinjector does
not decrease cell viability, and it has a very high initial success rate (up to 90%). With
the addition of an on-chip actuator, the nanoinjector could be packaged as an inexpensive,
fully automated system, enabling efficient, high volume genetic modification of developing
animals. Such a device would greatly increase the ease and speed of generating the model
organisms needed to study such critical diseases such as Alzheimer’s disease, cancer, and
diabetes.

ACKNOWLEDGMENTS

I would like to acknowledge the Ira A. Fulton College of Engineering and Technology for the Research Initiation Grant that funded the first year of this research. I would also
like to acknowledge the National Science Foundation for funding the most recent aspects
of my work.
I am also greatly indebted to the many individuals that have contributed to this
project. I would like to thank Dr. Jensen and Dr. Howell for their contributions to the
mechanical and electrical design of the MEMS nanoinjector, as well as all of their help
preparing publications documenting this research. Especially I am indebted to Dr. Burnett
for her many contributions to all the biological aspects of this work.
Thanks to Dr. David Kooyman and Dr. Jeffery Barrow for providing invaluable
experience and expertise in the area of mouse genetics and embryology. Thanks also go
to the members of the Compliant Mechanisms Research group and the MAFIA mouse
research group for their frequent help and support in overcoming the ever present hurdles
of research.
I would also like to thank my family, especially my wife Kimberlee, for the support
they have contributed over the two years of research on this project. Most of all, I would
like to recognize and express gratitude for the role of Divine inspiration in all aspects of
this work.

Table of Contents
List of Tables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

x

List of Figures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xii
Chapter 1 Introduction . . . . . . . . . . . . . . . . . . .
1.1 Microinjection and Microinjection Equipment . . . .
1.2 MEMS Applied to Microinjection . . . . . . . . . .
1.2.1 Previous MEMS Cell Constraining Methods
1.2.2 Previous MEMS Microinjection Needles . .
1.2.3 The Nanoinjector . . . . . . . . . . . . . . .
1.3 Thesis Outline . . . . . . . . . . . . . . . . . . . . .

.
.
.
.
.
.
.

.
.
.
.
.
.
.

.
.
.
.
.
.
.

.
.
.
.
.
.
.

.
.
.
.
.
.
.

.
.
.
.
.
.
.

.
.
.
.
.
.
.

.
.
.
.
.
.
.

.
.
.
.
.
.
.

.
.
.
.
.
.
.

1
1
2
3
3
4
5

Chapter 2 Mechanical Design and Testing of the Nanoinjector
2.1 Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . .
2.2 Introduction . . . . . . . . . . . . . . . . . . . . . . . . .
2.3 Functional Requirements . . . . . . . . . . . . . . . . . .
2.4 Device Description . . . . . . . . . . . . . . . . . . . . .
2.5 Analysis of Rigid-Body Elements . . . . . . . . . . . . .
2.6 Analysis of Compliant Elements . . . . . . . . . . . . . .
2.7 Kinematic Testing of Prototype Nanoinjectors . . . . . . .
2.8 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . .

.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.

7
7
7
9
10
14
15
18
21

Chapter 3 Electrostatic Attraction and Repulsion of DNA
3.1 Abstract . . . . . . . . . . . . . . . . . . . . . . . . .
3.2 Introduction . . . . . . . . . . . . . . . . . . . . . . .
3.3 Device Description . . . . . . . . . . . . . . . . . . .
3.4 Operational Requirements . . . . . . . . . . . . . . .
3.5 Experimental Method . . . . . . . . . . . . . . . . . .
3.5.1 DNA Visualization and Imaging Methods . . .
3.5.2 Image Post-processing . . . . . . . . . . . . .
3.6 Results . . . . . . . . . . . . . . . . . . . . . . . . . .
3.6.1 DNA Attraction Experiments . . . . . . . . . .
3.6.2 DNA Repulsion Experiments . . . . . . . . . .
3.7 Discussion of Results . . . . . . . . . . . . . . . . . .
3.8 Conclusion . . . . . . . . . . . . . . . . . . . . . . .

.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.

23
23
23
26
27
28
29
33
37
37
37
40
41

viii

.
.
.
.
.
.
.

.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.

Chapter 4 Microinjections Performed with the Nanoinjector
4.1 Abstract . . . . . . . . . . . . . . . . . . . . . . . . . .
4.2 Introduction . . . . . . . . . . . . . . . . . . . . . . . .
4.2.1 Device Description . . . . . . . . . . . . . . . .
4.3 Methods . . . . . . . . . . . . . . . . . . . . . . . . . .
4.3.1 Cell Culture and Device Preparation . . . . . . .
4.3.2 Performing Microinjections . . . . . . . . . . .
4.4 Results . . . . . . . . . . . . . . . . . . . . . . . . . . .
4.5 Discussion . . . . . . . . . . . . . . . . . . . . . . . . .

.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.

43
43
43
45
47
47
48
51
52

Chapter 5 Conclusions . . . . . . . . . . . . . .
5.1 Contributions to Engineering . . . . . . . .
5.2 Contributions to Molecular Biology . . . .
5.3 Future Work and Anticipated Contributions

.
.
.
.

.
.
.
.

.
.
.
.

.
.
.
.

.
.
.
.

.
.
.
.

.
.
.
.

.
.
.
.

.
.
.
.

.
.
.
.

55
55
56
57

.
.
.
.

.
.
.
.

.
.
.
.

.
.
.
.

.
.
.
.

.
.
.
.

.
.
.
.

References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
Appendix A Information on the dsRed1 Gene . . . . . . . . . . . . . . . . . . . 63
A.1 Abbreviated Map of the p-dsRed1-N1 Plasmid . . . . . . . . . . . . . . . . 63
A.2 Notes on dsRed1 in Transgenic Mouse Embryos . . . . . . . . . . . . . . . 64
Appendix B DNA Replication, Restriction Digest, and Purification Protocols
B.1 Replication of the p-dsRed1-N1 Plasmid . . . . . . . . . . . . . . . . .
B.1.1 Transform E. coli by Heat Shock . . . . . . . . . . . . . . . . .
B.1.2 Selectively Culture Transformed E. coli . . . . . . . . . . . . .
B.1.3 Plasmid Purification . . . . . . . . . . . . . . . . . . . . . . .
B.1.4 Liposome Mediated Transfection of Mammalian Cell Culture .
B.2 Restriction Digest of p-dsRed1-N1 to Isolate CMV-dsRed1 Construct. .
B.2.1 Restriction Enzyme Digest . . . . . . . . . . . . . . . . . . . .
B.2.2 Fragment Separation by Gel Electrophoresis . . . . . . . . . .
B.2.3 Gel Extraction Protocol . . . . . . . . . . . . . . . . . . . . . .

ix

.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.

67
67
67
68
68
68
68
69
70
70

List of Tables
2.1
2.2
2.3

Nanoinjector rigid link dimensions . . . . . . . . . . . . . . . . . . . . . . 14
Comparison of PRBM and FEA analyses of the folded beam suspension . . 16
Electrical connection reaction forces . . . . . . . . . . . . . . . . . . . . . 18

3.1
3.2

Estimated number of attracted DNA molecules . . . . . . . . . . . . . . . 37
Estimated number of repelled DNA molecules . . . . . . . . . . . . . . . . 39

4.1
4.2

Viability of control and injected embryos . . . . . . . . . . . . . . . . . . 51
Expression rates for ten injected embryos . . . . . . . . . . . . . . . . . . 51

A.1 Name and location of major features on p-dsRed1-N1 . . . . . . . . . . . . 63
A.2 Name and location of important restriction digest sites on p-dsRed1-N1 . . 64
B.1 Restriction enzyme digestion reagents . . . . . . . . . . . . . . . . . . . . 69

x

xi

List of Figures
1.1
1.2

Schematic representation of a microinjection station . . . . . . . . . . . . .
SEM of the nanoinjector . . . . . . . . . . . . . . . . . . . . . . . . . . .

2.1
2.2
2.3
2.4
2.5
2.6
2.7
2.8
2.9
2.10
2.11
2.12
2.13

SEM images of out-of-plane hinges . . . . . . . . . . . . . . . .
CAD images highlighting fabrication layers in scissor hinges . . .
Schematic of the nanoinjector . . . . . . . . . . . . . . . . . . .
Labeled SEM of the nanoinjector . . . . . . . . . . . . . . . . . .
Kinematic Diagram of the nanoinjector . . . . . . . . . . . . . .
Pseudo-rigid-body model of a fixed-guided beam . . . . . . . . .
Stress contour plots of the fully deflected folded beam suspension
FEA contour plot of the fully deflected electrical connection . . .
Images of an actuated lance mechanism . . . . . . . . . . . . . .
Angled view of the Nanoinjector lance mechanism . . . . . . . .
The nanoinjector constraining a latex sphere . . . . . . . . . . . .
Constraining a mouse zygote with the nanoinjector . . . . . . . .
SEM of parasitic scissor hinge motion . . . . . . . . . . . . . . .

.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.

10
10
11
12
15
15
17
17
19
19
20
20
21

3.1
3.2
3.3
3.4
3.5
3.6

.
.
.
.
.

24
26
27
28
29

3.9
3.10
3.11
3.12
3.13

Schematic representation of a typical microinjection . . . . . . . . . . . .
SEM of a MEMS lance assembly in its as-fabricated position . . . . . . .
SEM of the MEMS lance assembly in its deployed . . . . . . . . . . . .
Diagram of the electrical connections in the MEMS lance . . . . . . . . .
SEM of an electrolysis damaged bond pad . . . . . . . . . . . . . . . . .
Calibration curve for blue channel pixel intensity vs DAPI stained DNA
concentration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Electrical diagram of the lance and its voltage source . . . . . . . . . . .
Graphical representation of the background and concentrated DNA fluorescence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Illustration of an example concentration distribution . . . . . . . . . . . .
Concentration maps, histograms of Device 1’s positively charged lance .
Concentration map, histograms of Device 2’s positively charged lance . .
Concentration maps and histograms of DNA repulsion experiments . . . .
Concentration maps before and while repelling DNA . . . . . . . . . . .

.
.
.
.
.
.

34
35
38
38
39
40

4.1
4.2
4.3
4.4
4.5

Labeled SEM of the nanoinjector . . . . . . . . . . . . . . . . . . . . .
A kinematic and electrical schematic representation of the nanoinjector
An optical micrograph of the nanoinjector in use . . . . . . . . . . . .
Microscopy images showing embryo constraint method . . . . . . . . .
Fluorescent images of control and injected embryos . . . . . . . . . . .

.
.
.
.
.

46
47
49
50
52

3.7
3.8

xii

.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.

2
4

. 31
. 32

A.1 Annotated map of the p-dsRed1-N1 plasmid . . . . . . . . . . . . . . . . . 64

xiii

Chapter 1
Introduction

1.1

Microinjection and Microinjection Equipment
The creation of animals with foreign DNA inserted into their genome has become

increasingly important for researchers since such animals were first developed nearly 30
years ago. In 1980, Gordon et al. published the first successful production of transgenic
(an organism with artificially introduced genetic traits) mouse embryos by directly injecting
DNA into a fertilized mouse egg cell (zygote) in a process called microinjection [1]. One
year later, Gordon et al. reported on the successful transmission of genes from a genetically
modified mouse to that mouse’s offspring. These two works laid the foundation for the
study of the genetic factor affecting the immune system, growth and development, cancer,
Alzheimer’s disease, diabetes, and many other inheritable traits and conditions.
The microinjection process invented by Gordon et al. was further refined by other
researchers, most notably Brinster et al. in 1985 [2]. Brinster reported overall success rates
(the percentage of injected embryos that develop into transgenic offspring) between less
than 1% and 6% [2]. Since that time, reported microinjection success rates have remained
essentially constant [3]. Researchers have tolerated such an inefficient process because
it is often the only means of introducing foreign DNA into (transfecting) very delicate
embryonic cells. Other transfection methods, such as chemical, viral, or electrical methods,
work well in cell culture, but are widely known to cause high rates of embryo mortality,
often 100% [4]. One possible reason that microinjection rates have remained the same is
that the basic design concept for the microinjector has remained the same for almost 30
years.
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Cell Constraining
Micromanipulator

Injection
Micromanipulator

Injection
Pump

Suction
Pump

Inverted Microscope

Figure 1.1: A schematic representation of a typical microinjection station, including the
inverted microscope, micromanipulators, and external pumps.

Traditional microinjection systems have two main components that are manipulated
under a microscope: a finely drawn suction pipette for holding a cell in place during injection, and a second, much more finely drawn pipette that performs the injection. Figure 1.1
shows a typical microinjection system, consisting of an inverted microscope, a pair of micromanipulators, and a pair of very accurate pumps: one for providing suction, and one
for performing the injection. The injecting pump, for example, typically provides picoliter
accuracy when performing injections [5].
The basic microinjection equipment has recently undergone certain refinements,
such as the addition of robotic manipulators [6, 7], the use of force-feedback [8], and the
development of finer, more consistent microinjection needles [7, 9]. However, all of these
improvements do not deviate from the syringe-and-pump design concept, and none have
led to increases in microinjection success rates [6–8].

1.2

MEMS Applied to Microinjection
The similarities in scale between microelectromechanical systems (MEMS) and liv-

ing cells has created a great deal of interest in the development of MEMS devices for performing cellular manipulations, such as microinjection. MEMS researchers have focused

2

on two main areas pertaining to microinjection: constraining living cells, and improving
the microinjection needles used in microinjection.

1.2.1

Previous MEMS Cell Constraining Methods
Previously developed methods for constraining cells and other microscopic objects

can be broadly categorized as either digitated grippers or suction constraints. The simplest MEMS digitated grippers are similar in appearance to pliers or tweezers. Beyeler et
al. developed an electrostatically driven device that successfully grasped 74 µm diameter
polymer spheres submerged in water. Because it was actuated electrostatically only the
jaws can be submerged in water [10]. Chronis et al. developed a thermally actuated SU-8
gripper that successfully grasped individual cells less than 10 µm in diameter while fully
submerged in water [11].
More complex digitated grippers closely resembling a human forearm and hand
have been developed. A rather complex, thermally actuated gripper complete with an “elbow,” a “wrist,” and two or four “fingers” was used to deftly grasp and reposition 100 µm
diameter glass beads in an aqueous solution [12]. Chan et al. developed a less sophisticated
thermally actuated device consisting of one large “finger” capable of grasping much larger
objects (< 1 mm in diameter) [13]. Both devices use thermal actuation to achieve their
motion, which carries the risk of exposing the cells to damaging temperatures.
Finally, other researchers have investigated using MEMS suction devices to constrain cells. In his review on the subject, Maxwell cites several MEMS-scale suction devices specifically designed to constrain cells for biological assays [14]. Each of these devices requires an external pump, making them analogous to the suction pipettes currently
used in microinjectors.

1.2.2

Previous MEMS Microinjection Needles
The recent advances in MEMS-scale needles continue to adhere to the paradigm

of a needle consisting of a hollow structure through which liquid is forced via a pressure
differential. The MEMS-scale needles have reduced the needle bore or sharpened the tip of

3

Constraining Mechanisms

Lance Mechanism

Figure 1.2: A scanning electron micrograph of the nanoinjector grasping a latex sphere
much as it grasps an embryo during microinjection. The two constraining arms are visible
at the top of the image, while the lance mechanism is visible at the bottom of the image.

the needles using MEMS fabrication processes [7, 9]. Like current microinjector needles,
these MEMS-scale needles require an external pump to provide the pressure needed to
force material out of the needle and into a cell.

1.2.3

The Nanoinjector
The nanoinjector presented in this thesis, shown in Figure 1.2, performs all of the

functions of a current microinjector without the aid of external pumps. Rather than using a pressure differential from a pump to force liquid through a tube and into the cell,
the nanoinjector uses electrostatic charges to attract and repel DNA from the tip of a solid
polysilicon lance. The lance is part of a lamina-emergent, six-bar mechanism grounded
to a compliant [15], translating stage. The device also includes two lamina-emergent [16],
six-bar constraining mechanisms which physically hold the zygote in place during microinjection. The specific microinjection system presented here was designed to inject DNA into
zona pellucida enclosed mouse zygotes (approximately 100 µ in diameter).

4

Overall, the system is much simpler than traditional microinjectors in that it requires no external pumps, consists of only three kinematic mechanisms, and it reduces the
3-dimensional manipulation environment of typical microinjectors to the 2-dimensional
MEMS fabrication plane. In its current state of development, the nanoinjector has demonstrated the ability to perform all of the following microinjection tasks:
• Concentrate DNA on the tip of the lance using static electric charges
• Constrain the cell during microinjection
• Pierce the zona pellucida and cell membranes without causing cell death
• Release sufficient DNA into the cell for expression of the DNA
• Free the cell from the constraints for further growth and study
Future work on the nanoinjector’s mechanical design includes increasing the accuracy of the mechanisms’ out-of-plane joints, and adding an on-chip actuator to enable full
automation of the nanoinjector. In further biological experimentation, a fully developed
transgenic mouse is planned to be produced using the nanoinjector.

1.3

Thesis Outline
The design and testing of the nanoinjector is presented in the three following chap-

ters. Chapter 2 reports on the mechanical design of the nanoinjector. Chapter 3 details
proof-of-concept testing for the electrostatic attraction and repulsion of DNA to and from
the lance of the nanoinjector. Chapter 4 details the microinjections performed thus far on
mouse zygotes and the generation of several early-stage transgenic embryos. Both Chapters 2, 3, and 4 are technical papers, recorded in their entirety, each with an abstract and
introduction. Chapters 2 and 4 are in preparation for publication in peer reviewed journals,
and Chapter 3 is published in Reference [17].

5
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Chapter 2
Mechanical Design and Testing of the Nanoinjector1

2.1

Abstract
Microinjection is an important process for injecting foreign macromolecules, par-

ticularly DNA, into living cells. However, the complex, 3-dimensional manipulations involved in operating a modern microinjector require either a highly skilled operator, or complex automated equipment. This paper discusses the design and kinematic testing of a microelectromechanical system (MEMS) microinjector, termed a nanoinjector. The nanoinjector consists of two lamina-emergent cell constraining mechanisms, and one laminaemergent, metamorphic lance mechanism, each requiring only one linear input. Kinematic
testing and physical manipulation of latex spheres and mouse embryos demonstrated that
the nanoinjector is capable of performing the physical manipulations necessary for injecting DNA into living cells.

2.2

Introduction
Microinjection is an important process for injecting foreign macromolecules, par-

ticularly DNA, into living cells, especially developing embryos [1, 18]. The microinjection
procedure involves physical manipulation of the target cell in a three-dimensional environment (a drop of cell culture media) via a suction applied by a holding pipette and by forces
applied by a finely drawn hollow needle. The microinjection needle both rotates and aligns
the cell while on the holding pipette, and physically pierces the cell membranes during the
actual injection.
1 This

chapter consists of a journal article by co-authored by Quentin T. Aten, Brian D. Jensen, and Larry
L. Howell, and is currently under review for publication in an archival journal.
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Two independent, three-degree-of-freedom micromanipulators position the holding pipette and the microinjection needle during manipulations. Also, suction and pressure are respectively applied to the holding pipette and needle by precise pumps. In the
first microinjection systems, the micromanipulators and pumps were manually operated by
highly skilled technicians. The extensive training required to operate these first systems,
and the manual process’s low throughput, led researchers to develop more efficient microinjection systems. These have included robotically assisted systems operated by skilled
technicians [6, 8], and fully automated systems [7].
All of these technological advances, however, are based on the “capillary and pump”
paradigm established nearly 30 years ago. The physical manipulations performed during
the microinjection remain essentially unchanged, and increasingly sophisticated (and expensive) microinjection systems increase throughput by reducing the required amount of
human input rather than simplifying the manipulations themselves. Greater microinjection
throughput and simpler microinjection systems may be achievable if the required manipulations are simplified.
Microelectromechanical systems (MEMS) are a promising platform for the manipulation of living cells both because MEMS are fabricated on the same scale as living cells,
and because MEMS devices are capable of complex motions. Several researchers have developed MEMS devices for grasping, and/or moving, micro-scale objects, including living
cells, of various sizes [10–14].
We have developed a MEMS microinjection system, termed a nanoinjector, that
uses two mechanisms to physically constrain a fertilized mouse egg cell (zygote), and a
third mechanism to perform pumpless DNA injections on the zygotes. With the nanoinjector, cellular manipulations occur in the two-dimensional plane of the MEMS die, and these
manipulations are accomplished with only three linear inputs. This publication describes
the mechanical design of the nanoinjector, and its initial kinematic testing. The results of
injections performed with the device will be presented in other publications.
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2.3

Functional Requirements
The process of injecting a fertilized zygote with foreign DNA can be decomposed

into two essential tasks: constraining the cell and piercing the cellular membranes while
performing the actual injections. Each of these tasks must be performed while submerged
in cell culture media (a solution containing salts, nutrients, and pH buffers) and without
causing physical, thermal, electrical, or other damage to the cell. Finally, in order to reduce
the size, cost, and complexity of the injection system, the nanoinjector should perform
injections without the assistance of external, macroscale pumps.
The polyMUMPs fabrication process [19] was selected as the prototyping platform
for the nanoinjector, and provides two polysilicon structural layers (2 µm and 1.5 µm
thick) and a non-structural gold layer. Because the fabrication technology is well established, surface micromachined polysilicon devices can be readily transformed from laboratory prototypes into mass-produced products. However, standard thin-film fabrication
methods are limited to planar features with discreet thicknesses, which imposes significant
design challenges when large out-of-plane displacement are required.
Zygotes from the common laboratory mouse, mus musculus, are 80–100 µm in
diameter, and must have both their in-plane and out-of-plane motion constrained during
injections. Thus, the nanoinjector’s mechanical constraints must be capable of large outof-plane displacements to physically grasp the cell above its midline, located 40–50µm
above the die substrate, to effectively limit the cell’s out-of-plane motion.
To avoid generating out-of-plane displacements, the injections must be performed
at the cell’s midline, and along an axis normal to the cell membranes at the midline. Should
the cell be pierced by a body that is either rotating or moving transverse to the cell membranes, the cell’s membranes are likely to be torn, lysing (rupturing) the cell. Thus the
penetrating element must travel along a rectilinear path at approximately 40–50µm above
the substrate immediately prior to and during injections.
The functional requirement that the nanoinjector require no external pumps, combined with the rather simple planar fabrication technology, necessitates the use of a novel
injection method. We have developed an pumpless nanoinjection lance which uses electrostatic charges to accumulate DNA on the surface of a solid tapered body, the lance, and at
9

(a) SEM of a scissor hinge

(b) SEM of a substrate hinge

(c) SEM of a slider hinge

Figure 2.1: SEM images the three types of out-of-plane hinges used in the nanoinjector:
scissor hinges, substrate hinges, and slider hinges .

(a) CAD image of scissor hinges in their asfabricated position.

(b) CAD image of scissor hinges in folded position.

Figure 2.2: CAD images highlighting fabrication layers in scissor hinges. Blue structures
are in the first polysilicon structural layer and red structures are in the second polysilicon
structural layer.

the appropriate time, repel the DNA from its surface [17]. From a mechanical design standpoint, the electrostatic lance requires the inclusion of an electrical connection between the
lance and a fixed electrical connection, such as a bond pad, but this electrical connection
must not significantly interfere with or modify the lance mechanism’s motion.

2.4

Device Description
The limitations of the polyMUMPs process make traditional pin joints extremely

difficult or even impossible to manufacture at the joints between out-of-plane members.
The lamina-emergent six-bar mechanisms in the nanoinjector use “scissor hinges,” “substrate hinges,” and “slider hinges” specifically designed to provide out-of-plane motion in
10

Side View

Lance Mechanism

Top View

Egg Cell

Constraining Mechanisms

120°

Lance Mechanism

Constraining Mechanisms

Figure 2.3: Schematic drawing of the nanoinjector showing the lance mechanism and two
constraining mechanisms.

surface micromachined mechanisms [20, 21]. Examples of each of these hinge types are
shown in Figure 2.1. Also, CAD models of the scissor hinges are pictured in Figure 2.2(a)
in their as-fabricated position and in the deployed position in Figure 2.2(b).
The nanoinjector consists of three independently actuated mechanisms arranged in
a circular array (120◦ of separation between each mechanism). Two of the mechanisms
constrain the cell while the third mechanism includes the electrostatic lance for injecting
genetic material into the target cell. (see Figures 2.3, 2.4). With the mechanisms in a
circular array, 120◦ apart, the forces applied by the three arms will tend to align an offcenter cell as it is grasped.
The constraining mechanisms are lamina-emergent [16, 22], parallel-guiding, sixbar mechanisms, kinematically grounded to the chip substrate, and receiving a linear input
from a slider [23, 24]. The constraining mechanisms are designed to have a total vertical
displacement at the tip of 69.8 µm and a total horizontal tip displacement of 75.5 µm
from its fabricated position. The constraining mechanism’s large horizontal displacement
allows for a larger area into which the cell can be initially placed. The link lengths for the
constraining mechanisms are given in Table 2.1
The lance mechanism, like the constraining mechanisms, includes a lamina-emergent,
parallel-guiding, six-bar mechanism receiving a linear input from a slider. The lance mechanism is designed to reach an out-of-plane height of 49.3 µm (the approximate radius of
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Lance Mechanism
Bond Pad

Bond Pad

Electrical Connection

Six-Bar Mechanism

Lance

Folded Beam Suspension

Constraining Mechanisms

Figure 2.4: SEM of an nanoinjector with the lance mechanism and constraining mechanisms shown in their actuated positions.

the mouse zygotes), with an in-plane tip displacement of 41.7 µm. The link lengths for the
lance mechanism are given in Table 2.1.
However, unlike the constraining mechanisms, the lance mechanism is attached to
a compliant, parallel-guiding, folded beam suspension via slider hinges. The folded beam
suspension provides an additional 70 µm of in-plane travel (see Figure 2.4). The translating
stage is designed to be sufficiently stiff to allow the lance mechanism to displace to its full
height with minimal horizontal displacement in the folded beam suspension. Actuating
the slider further engages a mechanical stop, causing the translating stage to deflect and
move the lance horizontally in its fully extended configuration an additional 70 µm. Thus,
the lance mechanism is a metamorphic mechanism [25], with a distinct two-stage motion:
the six-bar mechanism’s out-of-plane motion, followed by the folded beam suspension’s
in-plane motion. Though both stages of motion are driven by a single input, they are
decoupled in the sense that each motion occurs independently of the other.
The parallel nature of the mechanisms’ motion, especially the lance mechanism,
is key to the nanoinjector’s successful operation. By remaining parallel to the substrate
as they interact with the cell, the constraining mechanisms minimize the possibility of
tearing or otherwise damaging the cell by combined translation and/or rotation at the at the
constraining interfaces. Similarly, the lance’s two stage motion minimizes the likelihood
12

of membrane damage by allowing the six-bar mechanism to reach its full height before
contacting the cell, and then pierce the cell along a purely linear path, approximately normal
to the cell’s membranes.
Finally, the lance is electrically connected to two bond pads, via a par of compliant
serpentine flexures. The lance and its associated bond pads, together with the monosilicon
substrate, form a 230 pF capacitor. This capacitance allows an electrostatic charge to be applied to the lance by connecting a DC voltage source to the lance and the substrate [17]. The
electrical connections’ thin undulating flexures are designed to provide as little mechanical
resistance to the lance’s motion as possible. Additionally, the electrical connection is attached to either side of kinematic link containing the lance (link R1 ) halfway between the
two vertical links (link R4 ) to prevent the generation of moments that might cause the lance
to rotate about a horizontal axis (see Figures 2.4, 2.5).
Considering the mechanism as a whole, the nanoinjector’s operation consists of the
following steps.
1. Introduce genetic material into the solution containing the nanoinjector.
2. Apply a positive charge to the lance mechanism to accumulate DNA on the lance.
3. Place a cell at the center of the nanoinjector.
4. Raise the constraining mechanisms to align and constrain the cell.
5. Raise the lance mechanism to its full height.
6. Move the lance toward the cell by deflecting the folded beam suspension until the
cell membranes have been pierced.
7. Reverse the electrical polarity of the lance to repel the DNA.
8. Lower the lower the lance mechanism and constraining mechanisms and retrieve the
cell for further growth and study.
It is worth noting that, with the exception of pick-and-place operation required to deliver a
cell to the nanoinjector, all of the nanoinjection steps are performed using only three linear
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inputs in the two-dimensional plane of the MEMS die. The pick-and-place operation is
the most sophisticated manipulation, but can be accomplished in a simple 2.5 dimensional
motion: lift the cell to a predetermined height, move the cell to the approximate center of
the nanoinjector, lower the cell to the substrate surface.

2.5

Analysis of Rigid-Body Elements
The six-bar’s kinematic model is pictured in Figure 2.5. The scissor hinges, sub-

strate hinges, and slider hinges can all be approximately analyzed as traditional rigid body
pint joints. The six-bar mechanism’s kinematics are described in Equations 2.1–2.4. The
dimensions for the constraint mechanisms’ and the lance mechanism’s rigid links along
with each mechanism’s input and output displacements are given in Table 2.1.
(R4 +R5 −Xin )2 +R24 −R25
2×R4 ×(R4 +R5 −Xin )

(2.1)

θ5 = 2π + arcsin( RR45 × sin(θ4 ))

(2.2)

θ4 = arccos

θin

= θ5 − π

(2.3)

Zout

= R4 × sin(θ4 )

(2.4)

Table 2.1: Key kinematic dimensions of the constraining mechanism and lance
mechanism corresponding to the kinematic diagram in Figure 2.5. All
dimensions are in µm unless otherwise noted.
Constraining Mechanism
R1
120
R4
70
R5
175
Xin
100
Zout
69.8
Xout
75.5
Lance Length
N/A
Lance Taper
N/A
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Lance Mechanism
120
50
145
50
49.3
41.7
150
10◦

R1

R4

R5

R4

As Fabricated Position

X out
R1
Zout

R4

R4

θ4

X in

θ5
θ4

θin

R5

Deployed Position

Figure 2.5: Kinematic diagram of the lamina-emergent, parallel-guiding, six-bar mechanism used in the nanoinjector.
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Figure 2.6: Fixed-guided beam and its pseudo-rigid body model.

2.6

Analysis of Compliant Elements
The eight flexible segments in the folded beam suspension (see Figure 2.4) were

modeled as fixed-guided compliant segments. For one half of the mechanism, the inner
flexures displace in parallel, as do the outer flexures. The inner flexure pair is in series with
the outer flexure pair. Taking both sides of the folded beam suspension in parallel gives a
total mechanism stiffness equal to the stiffness of two individual flexible segments.
The eight compliant members are 300 µm long, 5 µm wide, and 2 µm thick. The
flexures were first analyzed using a pseudo-rigid-body model (PRBM) [15], which replaces
the non-linear deflection problem with a rigid-body kinematic analog. A diagram of the
deflected beam and the rigid body analog are shown in Figure 2.6. The equations for
determining the force required to produce a prescribed deflection in the y direction and the
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resultant maximum stress of the compliant stage are given in Equations 2.5-2.9.
Θ = arcsin

b
γl

(2.5)

α 2 = 2KΘ Θ

(2.6)

P = 4α 2 EI/l 2

(2.7)

a = l(1 − γ(1 − cos Θ))
Pa( h2 )
σmax =
2I

(2.8)
(2.9)

where b and a are the y direction and x direction deflection of the beam, E is Young’s modulus for polysilicon (≈ 164 Gpa), I is the second moment of inertia for a rectangular beam,
γ = 0.8517, and KΘ = 2.65. The calculated input force and maximum stress predicted by
the pseudo-rigid-body model for a displacement of 69 µm are given in Table 2.2
A non-linear (large deflection with strain stiffening) finite element analysis (FEA)
was performed on the folded beam suspension using ANSYS 11.0 to corroborate the forces
and stresses predicted by the pseudo-rigid-body model. As before, the folded beam suspension was displaced 69 µm and the maximum stresses in the structure were recorded in
Table 2.2. The FEA predictions agree quite well in their estimation of the force required
to move the stage 69 µm, and in the magnitude of the maximum stress. As expected, the
maximum stresses shown in Figure 2.7 are concentrated at the 90◦ intersection of the flexible and rigid segments. The MUMPs fabrication process prevents the creation of sharp
right angles by naturally incorporating fillets at all corners. Considering the FEA model as
a worst-case stress condition, the results indicate the compliant stage will remain below the
1500 MPa ultimate strength of polysilicon.

Table 2.2: Comparison of PRBM and FEA analyses of the folded beam suspension.
PRBM
Force Total
220 µN
Maximum Stress 958 MPa
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FEA
198 µN
1033 MPa

Figure 2.7: FEA contour plots of folded beam suspension stage displaced 69 µm with
stresses depicted in MPa. Note the areas of stress concentration at the flexures’ fixed ends.

Figure 2.8: FEA contour plots of electrical connection stage displaced 50 µm vertically and
111 µm horizontally, with stresses indicated in MPa. Note the area of stress concentration
at the corner in the flexure’s free end highlighted in the inset.

In the absence of a closed-form approximation for the kinematics of serpentine
flexures, the electrical connection was analyzed with non-linear FEA. The free end of the
electrical connection was displaced 50 µm vertically (the approximate final elevation of
the lance mechanism) and 111 µm horizontally. The maximum stress was calculated as
308 MPa at the junction of the flexible segment with the bond pad (See Figure 2.8).
The reaction forces were calculated for the electrical connection’s free end to determine the resulting load placed on the six-bar lance mechanism. Table 2.3 presents the
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force results for the free end according to the coordinate system shown in Figure 2.8. With
a total force for both connections of 3.4 µN in the horizontal direction and 32 µm in the
vertical direction the electrical connections are not likely to impede the performance of the
mechanism.

2.7

Kinematic Testing of Prototype Nanoinjectors
Prototype nanoinjectors were fabricated using the polyMUMPs process, and the de-

vices were actuated using microprobes. Figure 2.9 demonstrates both the lamina emergent
behavior of the six-bar mechanism and the two stage, metamorphic, behavior of the lance
mechanism. A lance mechanism is shown in Figure 2.9(a) in its as-fabricated position.
Figures 2.9(b) and 2.10 show the six-bar parallel-guiding mechanism common to both the
lance mechanism and constraining mechanisms in its fully deployed position. Figure 2.9(c)
shows the second stage of the lance mechanism’s motion with the folded beam suspension
in its deflected position.
The electrical connection’s serpentine flexures did not interfere with the motion of
the six-bar-mechanism or the translating stage, as show shown in Figures 2.9(b) and 2.9(c).
Interestingly, the electrical connections provide so little resistance to the lance mechanism’s
motion that the six-bar mechanism can remain in its fully erected position without actuation, as shown in Figure 2.10.
In the second phase of kinematic testing the nanoinjector was used to physically
constrain both a 100 µm-diameter latex sphere and living mouse zygotes. The latex sphere
is approximately the same diameter as mouse zygotes, makes a good physical analog for
the actual cells, and can be manipulated without submerging the die in liquid. As shown

Table 2.3: Reaction forces applied to the lance mechanism by one or both electrical
connections for a displacement of 50 µm horizontally and 100 µm vertically.
One
Fx Total −3.51 µN
Fy Total
1.70µN
Fz Total −16.0 µN
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Both
−7.02 µN
3.40µN
−32.0 µN

(a) Nanoinjector
fabricated.

lance

as- (b) Nanoinjector 49 µm above the (c) Compliant base sliding an adsubstrate.
ditional 50 µm.

Figure 2.9: Nanoinjector in its as-fabricated, fully deployed, and fully translated positions.
The mechanism is being actuated by a microprobe.

Figure 2.10: Angled optical microscopy image of a deployed nanoinjector lance mechanism.
in Figure 2.11, the nanoinjector constrained the latex sphere in both the in-plane and outof-plane directions. Figure 2.11(b) shows how the constraining mechanisms interface with
the sphere above its midline to provide the required out-of-plane constraint.
The nanoinjector’s ability to perform the manipulations required for injecting DNA
into zygotes was further demonstrated by performing “mock” injections on living mouse
zygotes. The mock injection procedure consists simply of constraining, piercing, then
releasing the mouse zygote. Figure 2.12 shows two examples of manipulating zygotes
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(a) Optical image of the nanoin- (b) SEM of the nanoinjector con- (c) SEM of the nanoinjector conjector constraining a latex sphere straining a latex sphere
straining a latex sphere

Figure 2.11: An optical microscopy image, and scanning electron micrographs of the
nanoinjector constraining a 100 µm-diameter latex sphere.

(a) Nanoinjector constraining a mouse zygote

(b) A mouse zygote sliding under the constraining
mechanisms

Figure 2.12: An optical image of a mouse zygote being successfully constrained by the
nanoinjector (a), and an optical image of a zygote sliding under both constraining mechanisms (b), likely due to the parasitic motion in the scissor hinges shown in Figure 2.13.

with the nanoinjector. Figure 2.12(a) shows the nanoinjector successfully constraining
and piercing a zygote. The nanoinjector successfully constrained and pierced zygotes approximately 90–100 µm in diameter using only the constraining and lance mechanisms.
Experimentation is ongoing to quantify the nanoinjector’s effect on embryo viability, and
initial results are suggesting the nanoinjector does not decrease embryo viability.
The zygotes have a natural size distribution, and some of the zygotes used in testing
have diameters at the lower end of the expected diameters, approximately 80 µm. Fig-
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Currnet Location
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Hinge

Location of
Theoretical Hinge

Figure 2.13: A scanning electron micrograph showing the parasitic motion inherent in the
scissor hinges used in the nanoinjector. The hinge has a total of 14 µm of possible parasitic
motion in the out of plane direction.

ure 2.12(b) shows one such cell, which was small enough to slide under the constraining
mechanisms.
An unforeseen consequence of using scissor hinges for the out-of-plane members
is the potential for significant parasitic motion in the out-of-plane direction, as shown in
Figure 2.13. As employed in the nanoinjector the scissor hinges have a total of 14 µm of
potential out-of-plane parasitic displacement. Consequently, with the constraining mechanisms at their theoretically predicted height of 69.8 µm, the two mechanisms can simply
slide over zygotes with diameters less than ≈ 84 µm, as shown in Figure 2.12(b).

2.8

Conclusion
The nanoinjector’s large out-of-plane displacements and the lance mechanism’s

metamorphic motion are uniquely suited for constraining and injecting mouse zygotes.
The device’s constraining mechanisms are able to constrain the mouse zygotes 90–100 µm
in diameter while maintaining a favorable orientation in relation to the cell. Reducing the
constraining mechanisms’ out-of-plane height, or employing fully compliant hinges, will
allow the nanoinjector to accommodate embryos with smaller diameters.
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The lance mechanism’s metamorphic, two-stage motion allows it to reach its full
height before contacting the cell, and then translate toward the cell, piercing it approximately normal to the cell’s membranes. In very preliminary work, no decrease in embryo
viability has been observed, possibly suggesting that the physical trauma caused by the
nanoinjector is not detrimental to embryo growth.
Finally, the nanoinjector is operated in a 2-dimensional manipulation environment
that is much simpler than the 3-dimensional manipulation environment of a standard microinjection chamber. The manipulations required to operate the nanoinjector consist of
simple pick and place operations with the target cell, and three linear inputs to the nanoinjector’s three mechanisms.
A MEMS mechanism-based approach to microinjection has greatly simplified both
the manipulations and equipment required to perform a very delicate biological task. The
incorporation of three on-chip linear actuators will allow automated operation of the nanoinjector, further increasing the efficiency and simplicity of the microinjection task by eliminating the three manual inputs. Injections of foreign DNA have been performed using the
nanoinjector, and will be reported in subsequent publications.
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Chapter 3
Electrostatic Attraction and Repulsion of DNA 1

3.1

Abstract
The ultimate goal of this work is to develop an automated MEMS-based system

for inserting foreign DNA into a living cell. This paper outlines one phase of that work:
testing the attraction and repulsion of DNA to and from the surface of a polysilicon MEMS
lance for use in the proposed MEMS-based injection system, termed a nanoinjector. The
pumpless MEMS nanoinjection lance operates on the principle of attraction and repulsion
of DNA using electrostatic charges. Prototype lances were fabricated using a multi-layer
surface micromachining process. DNA stained with a fluorescent dye (4‘,6-diamidino-2phenylidole dihydrochloride or DAPI) was visualized using fluorescent illumination as the
DNA was attracted to and repelled from the tips of MEMS microlances using a 1.5 V DC
source. The pumpless MEMS nanoinjection lance represents an important and significant
step in the development of a self-contained, automated, MEMS-based microinjection system.

3.2

Introduction
Microinjection is a process for introducing foreign compounds, particularly DNA,

into a living cell. In general, when a eukaryotic (nucleus-containing) cell expresses foreign
DNA artificially added to its genome through a process such as microinjection, the cell is
1 Portions

of this chapter were originally presented as a conference paper co-authored by Quentin T. Aten,
Brian D. Jensen, and Sandra H. Burnett: “Testing of a Pumpless MEMS Microinjection Needle Employing
Electrostatic Attraction and Repulsion of DNA,” 2008 Proceedings of the ASME International Design Engineering Technical Conferences and Computers and Information in Engineering Conference, DETC2008. A
journal article reflecting the most recent revisions to this chapter is currently in the review for publication in
an archival journal.
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Figure 3.1: A schematic representation of a typical microinjection. The suction pipette
holds the cell in place while the capillary needle pierces the cellular and nuclear membranes
and injects a solution containing DNA into the cell’s nucleus.

said to be transfected. More specifically, when foreign DNA is successfully microinjected
into a fertilized egg cell, cells arising from that egg will carry this additional genetic material. Thus, organisms can be produced which exhibit additional, enhanced, or repressed
genetic traits. For example, researchers used microinjection to create a strain of mice that
carries a foreign genetic construct which causes macrophages (a type of white blood cell)
to auto-fluoresce and undergo apoptosis (programed cell death) when exposed to a certain
drug [26]. These mice have since played critical roles in investigations of macrophage
activity during immune responses and macrophage activity during tumor growth [27, 28].
Current microinjectors function in much the same manner as macro-scale syringes:
a pressure differential forces a liquid through a needle and into the cell. Specifically, a very
fine, drawn glass capillary needle pierces the cell and nuclear membranes. Then, precise
pumps expel minute amounts of genetic material from the needle and into the nucleus [1].
Figure 3.1 shows a drawing of a cell undergoing microinjection. Recent work on microinjection has shown that the physical process of microinjection, specifically the injection of
extracellular fluids, damages the target cell’s chromosomes and may be a principal contributor to decreased embryo viability following microinjection [29]. Developmental arrest
and/or cell death is typically observed in 20–50% of microinjected embryos [1–3, 29].
In recent years, MEMS researchers have produced even finer microinjection needles
from silicon nitride [7] or silica glass [9]. Both of these needles are smaller than fire drawn
capillaries. However, these needles employ macro-scale pumps similar to those used in
traditional microinjectors, and will be prone to the same type of genomic damage seen in
more traditional microinjection systems.
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A self-contained MEMS microinjector requires either the development of integrated
micro-scale pumps and needles, or the development of a micro-scale “needle” which requires no pumps. A pumpless microneedle is made feasible by the unequal charge distributions within DNA molecules. The phosphate backbone of DNA has a net charge of one
electron per phosphate, giving a total of two electrons per base pair [30]. This net negative charge on the outer backbone of the DNA makes it possible to move DNA from one
point to another using the electric field generated by electrostatic charges. For example,
electric fields move DNA several inches through agarose or polyacrylamide gels during
macro-scale electrophoresis experiments [31, 32].
Similarly, on the MEMS scale, researchers have used electric fields to perform electrophoresis in microcapillaries [33], and to move nanoliter drops of DNA through a selfcontained DNA analysis system [34]. Using these devices as inspiration, we developed a
pumpless, solid, polysilicon, MEMS lance which attracts and repels DNA using electrostatic charges. The device is referred to as a “lance” rather than a “needle” both to emphasize its solid, not hollow, design, and to clearly distinguish between this new technology
and existing microinjection needles. The pumpless lance potentially has the important benefit of not introducing measurable amounts of extraneous liquid into a cell during injection,
possibly decreasing or eliminating the genomic damage seen in traditional microinjection.
When fully integrated into a pumpless MEMS microinjection system (referred to as
a “nanoinjector” to clearly distinguish it from existing microinjectors), the lance’s operation
will consist of four main steps:
1. The lance electrostatically attracts DNA onto its outer surface.
2. With DNA bound to its surface, the lance pierces the cellular and nuclear membranes
of the egg cell.
3. The lance electrostatically repels DNA from its outer surface and into the cell.
4. The lance retracts from the cell.
The results presented in this paper demonstrate the two most novel steps in the
operation sequence: the successful electrostatic attraction and repulsion of DNA using a
25
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Bond Pad
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Figure 3.2: SEM of a MEMS lance assembly in its as-fabricated position. The main components of the microlance assembly are labeled: the lance, the links of the six-bar mechanism
into which the lance is incorporated, the folded beam suspension onto which the six-bar is
mounted, and the electrical connections between the lance and bond pads.

MEMS lance (i.e. steps 1 and 3 above). Results of injections performed with the lance will
be reported in future publications, and are not presented in this paper.

3.3

Device Description
Prototype MEMS lances were fabricated using the polyMUMPs fabrication tech-

nology, which provides for two structural layers (2.0 µm and 1.5 µm thick respectively)
and a gold layer [19]. The process is relatively simple, and thus serves as a good prototyping platform for polysilicon MEMS devices intended for low cost commercial fabrication.
A prototype MEMS microlance is shown in Figures 3.2 and 3.3. The lance is incorporated into a kinematic mechanism consisting of a change-point parallel-guiding six-bar
mechanism, and a compliant parallel-guiding folded-beam suspension [15]. The kinematic
mechanism provides the range of motion necessary for performing nanoinjections on fertilized mouse egg cells, which are approximately 100 µm in diameter. However, similar
or identical electrostatic lances could be incorporated into other mechanisms or devices for
performing injections on other cell types.
The lance consists of a solid, tapered body (shown in Figures 3.2 and 3.3) having
a nominal thickness of 2 µm, and a minimum tip width of 150 nm. The lance is 120 µm
long and tapers at a 10◦ angle to a maximum width of 11 µm. As the sharpest feature
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Figure 3.3: Scanning electron micrograph of the MEMS lance assembly in its deployed
position 50 µm above the substrate of the MEMS die.

on the device, the lance will be the location of highest charge concentration and strongest
electric field. Therefore, the tip of the lance will be one of the most probable locations for
accumulating DNA.
Two highly folded electrical connections (shown in Figure 3.2) provide an electrical
path between the lance and the two bond pads. Gold wire bonds connect the bond pads to
an external voltage source.
Figure 3.4 illustrates how an external voltage source is connected to the MEMS
lance. One terminal of the voltage source is connected to the lance and the other is connected to the monosilicon substrate of the MEMS die via a bond pad placed over a cut in
the die’s insulating nitride layer. When connected in this manner and submerged in 0.9%
NaCl solution, the lance mechanism has a capacitance of approximately 230 pF.

3.4

Operational Requirements
To be employed in a practical, self-contained nanoinjector, the pumpless MEMS

lance must satisfy four operational requirements. First, and most importantly, the lance
must operate while submerged in cell culture media, which are aqueous solutions containing salts, pH buffers, nutrients and other dissolved components. In the following exper-
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Figure 3.4: Diagram of the electrical connections in the MEMS lance used to apply voltage
during DNA attraction and repulsion. Using the connection shown the MEMS lance had a
capacitance of approximately 230 pF.

iments the MEMS lance is submerged in 0.9% NaCl solution (saline solution) which is
isotonic with mammalian cells, and has approximately the same electrical properties as
more complex cell culture media.
Second, to be practically useful, the MEMS lance must concentrate measurable
amounts of DNA on its surface in a reasonably short amount of time.
Third, to increase the likelihood of cell survival, the MEMS lance must remain
inside the cell for as little time as possible; e.g. the lance must be capable of repelling DNA
concentrated on its surface in a matter of seconds.
Fourth, to prevent damage to the device or the cell, and to prevent unwanted bubble
formation, the MEMS lance must not cause electrolysis of the surrounding water.
The fourth constraint, not causing electrolysis of the water surrounding the MEMS
lance, is particularly limiting. In initial feasibility testing, electrolysis occurred at approximately 1.8 V on gold bond pads submerged in an aqueous solution of 0.9% NaCl (i.e. saline
solution). When electrolysis was allowed to occur, delamination of gold-on-polysilicon
bond pads, and near complete removal of gold from gold-on-polysilicon bond pads were
observed as shown in Figure 3.5. Thus, electrolysis established an effective ceiling of 1.8 V
for the MEMS lance’s operating voltage.

3.5

Experimental Method
The experimental method for demonstrating the pumpless MEMS lance’s feasibility

consisted of three main phases. First, we developed a linear model to relate the intensity of
light emitted by fluorescently stained DNA to the concentration of DNA present. Second,
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Figure 3.5: A scanning electron micrograph of a damaged gold on polysilicon bond pad
after serving as the anode during electrolysis in an aqueous solution of 0.9% NaCl. The
damaged bond pad has been stripped of much of its gold layer. Compare to the undamaged
bond pad at the right of the image.

we observed and quantified the attraction and repulsion of DNA by MEMS lances submerged in 0.9% saline solution. Third, digital images of the lances were post-processed in
MATLAB using the linear model developed in the first step. The post-processing generated
concentration maps, concentration histograms, and a quantitative estimate of the number
of DNA molecules released from the MEMS lance during the DNA repulsion experiment.
The protocols for each of these phases are outlined in the following sections.

3.5.1

DNA Visualization and Imaging Methods
DNA can be visualized using a variety of fluorescent stains. Fluorescent stains’

performance is defined by two wavelengths: the excitation maximum, and the emission
maximum. The excitation maximum is the wavelength of light that will evoke the strongest
fluorescence from the stain. The emission maximum is the wavelength of light emitted
with the greatest intensity by an excited stain molecule.
For this research 4‘,6-diamidino-2-phenylidole dihydrochloride (DAPI) was used
to visualize the DNA. DAPI was selected because of its low toxicity and its strong fluo-
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rescence under ultra-violet illumination. When dissolved in water and not bound to DNA,
DAPI has an excitation maximum of 355 nm (ultra-violet light) and and emission maximum of 453 nm (blue light) [35]. When DAPI is bound to DNA its excitation maximum
changes to 388 nm and its emission maximum shifts slightly to 454 nm [36], and the intensity of the emitted light increases roughly twenty-fold compared to free DAPI [35]. The
dramatic increase in emission intensity when DAPI binds with DNA makes it possible to
distinguish between any unbound DAPI and DAPI-stained DNA.
The DAPI-stained DNA was visualized using a Zeiss Axioskop Fluorescence Microscope with UV illumination and a filter(365 nm excitation 445 nm emission) for imaging
DAPI stained samples. All DNA fluorescence images used in this paper were taken at the
same camera settings (six second exposure, 70% saturation, and a linear brightness scale).
Since the DAPI-DNA complex fluoresces in the blue portion of the visible spectrum and
the emission filter transmits only blue light, the blue color channel was isolated from the
raw RGB images to simplify the image analysis process.
To provide quantitative estimates of the concentration of DNA on or near the lance,
a regression model was made of blue pixel intensity (I) as a function of DNA concentration
(C). DAPI stained DNA samples of known and uniform concentration were imaged using
the aforementioned parameters, and the mean blue channel pixel intensities of the images
were calculated using a MATLAB script. The relationship between concentration in ng/µL
and blue pixel intensity is linear as shown in Figure 3.6. A linear fit to the data gives the
relationship
C = (I − 83.07)/36.788

(3.1)

Because of the long exposure used (six seconds), the intercept value (blue pixel
intensity at 0 ng/µL) is highly susceptible to changes in ambient lighting conditions. In
cases where the ambient lighting conditions caused the intercept to deviate from the value
of 83.07 shown in Eq. 3.1, a reference image of a MEMS die submerged in 0.9% NaCl
with no DNA present was used to calculate the value of the intercept under those lighting
conditions.
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Linear Regression of Blue Channel Intensity vs Concentration
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Figure 3.6: Calibration curve for blue channel pixel intensity vs DAPI stained DNA concentration. The blue channel intensity measurements are shown with 95% error bounds.
The linear model of the data given in Eq. 3.1 is represented by the solid line.
DNA Attraction Experiments.
The DNA attraction experiments followed the protocol outlined below.
1. The MEMS die was covered in approximately 2 mm of 0.9% saline solution.
2. A 1-2 µL drop of 306 ng/µL DAPI stained DNA was placed in the solution near the
device using a calibrated pipette.
3. As shown in Figure 3.7, the lance was connected to the positive terminal of a voltage
source providing 1.5 V DC. The substrate of the MEMS die was connected to the
negative terminal of the voltage source.
4. Images were taken using the same microscope and same exposure settings as the
calibration images. Images were taken until DAPI-stained DNA was clearly visible
on the surface of the lance.
5. The time between the connecting the lance to the positive terminal and when DNA
was clearly visible on the lance was calculated.
6. The images were post-processed as described in Section 3.5.2.
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Figure 3.7: A diagram of the connections between the lance and the voltage source during
attraction and repulsion experiments.

DNA Repulsion Experiments.
The DNA repulsion experiments followed the protocol outlined below.
1. With DNA attracted to the tip of a MEMS lance, the polarity of the device was
reversed. As shown in Figure 3.7, the lance was connected to the negative terminal
of the 1.5 V DC voltage source, and the MEMS die substrate was connected to the
positive terminal of the voltage source.
2. Images were taken using the same microscope and same exposure settings as the
calibration images. An image was taken at the same time that the polarity of the
device was reversed.
3. The time between connecting the lance to the negative terminal and when DNA was
clearly repelled from the lance was calculated.
4. The images were post-processed as described in Section 3.5.2.
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3.5.2

Image Post-processing
The raw digital images produced during the DNA attraction and repulsion experi-

ments were post-processed to generate concentration maps of the DNA on and around the
lance, and to produce an estimate of the mass of DNA and number of individual DNA
molecules attracted to the tip of the lance.
TIFF images produced by the microscope were cropped to only include the lance
and the solution immediately surrounding the lance. Using MATLAB, the blue channel
pixel intensities were extracted from the images. Equation 3.1 was then applied to each
image using the mean blue pixel intensity of an image without DNA as the zero offset to
compensate for ambient lighting conditions.
A bounding region 10 pixels (6.5 µm) from the sides and tip of the lance’s profile
was defined for each image. This region defined a “reduced image” within the “full image”
containing the attracted DNA at or near the lance’s surface.

Identification of Background DNA Fluorescence
At this point in the post processing, each pixel’s concentration is the sum of the
background (diffuse) DNA fluorescence within the area covered by that pixel and, if present,
the attracted (concentrated) DNA within the are covered by that pixel. The background concentration will change with time as DNA near the surface, originally placed over the device,
diffuses throughout the bulk liquid. This concept is shown graphically in Figure 3.8, and
can be represented in a very simple mathematical form as
Ctotal = Cbackground +Cattracted

(3.2)

Using this relationship, the concentration of the attracted DNA (Cattracted ) at an individual pixel can be estimated from the total concentration at that pixel (Ctotal ) if an estimate
of the background concentration (Cbackground ) is obtained. However, the background DNA
concentration and the resulting pixel intensity are not uniform; rather the background DNA
concentration follows a random distribution. The background concentration is assumed to
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Figure 3.8: Graphical representation of the background and concentrated DNA fluorescence. The intensity value of each pixel represents the sum of the intensity of the background DNA and the attracted DNA.

be normally distributed, and can be seen as the peak within the example histogram shown
in Figure 3.9, while the attracted DNA appears in the right tail of the distributions.
The mode of the distribution (mode(C)) was found, and based on the assumption the background distribution is normally distributed, the mode was assumed to be
equal to the mean centered within the normal background distribution. The minimum observed concentration (min(C)) was taken as the lower bound of the background distribution
(LBCbackground ). The difference between the minium DNA concentration and the mode of
the concentration distribution is taken as half the width of the background normal distribution.
1
∆Cbackground = mode(C) − min(C)
2

(3.3)

The upper limit of the background concentration (UBCbackground ) is then established 21 ∆Cbackground
to the right of the distribution’s mode.
1
UBCbackground = mode(C) + ∆Cbackground
2

(3.4)

The upper and lower bounds of the example background distribution are shown graphically
in Figure 3.9.
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Figure 3.9: Illustration of an example concentration distribution showing the normally distributed background DNA, and region of the distribution containing the attracted DNA.

Normalization of the Attracted DNA Distribution
Having established the upper and lower bounds of the background distribution, all
pixels with concentrations above the background distribution’s upper limit were assumed
to contain attracted (concentrated) DNA. The concentration of the attracted DNA at an
individual pixel (Cattracted ) with a total concentration (Ctotal ) above UBCbackground could
then be estimated by approximating the overall background concentration(Cbackground ) as
Cbackground = mode(C)

(3.5)

and then rearranging Equation 3.2 to give
Cattracted = Ctotal − mode(C).

(3.6)

This process normalizes the distribution of attracted DNA by subtracting off the offset in
concentration caused by the background distribution.

Estimation of the Quantity of DNA Attracted
Finally, the total mass and number of attracted DNA molecules within the “reduced
image” bounding box around the lance (the red line on the concentration maps in Figures 3.10–3.13) were calculated. First, the pixels with intensities greater than UBCbackbround ,
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and lying withing the bounding box, were identified as shown in Figure 3.13. Then, the
mass of attracted DNA (mattracted total ) in nanograms was calculated by
i
N h
mattracted total = ∑ (Ctotal (i) − mode(C)) × w2pixel × d ×
i=1

1 µl
109 µm3

(3.7)

where Ctotal (i) is the total concentration in ng/µl at a single pixel with an intensity greater
than UBCbackbround and lying within the bounding box, N is the total number of such pixels,
w pixel is edge length of a pixel in µm (0.65 µm), and d is an assumed depth of the attracted
DNA in the out-of-plane direction equal to 1 µm. The mass of attracted DNA scales linearly with the assumed depth of the attracted DNA, and as such a conservative value of
50% of the lance’s total thickness was selected.
The number of attracted DNA molecules can then be estimated by calculating
nattracted total = mattracted total × NBP × mBP

(3.8)

where NBP is the number of base pairs in the DNA molecule being manipulated (4700 BP
for these experiments), and mBP is the average mass of a base pair of DNA (1.08671 ×
10−12 ng/BP).
For the DNA repulsion experiments, Equations 3.7 and 3.8 were used to estimate
the mass and number of DNA molecules attracted to the lance before and after reversing its
polarity. Both images were taken without moving the sample or the microscope; e.g. the
two images are completely aligned. The image taken prior to reversing the lance’s polarity
(attracting) was processed as outlined above, and the locations of pixels with concentrations
greater than UBCbackbround and lying within the bounding box were stored. The image
taken as lance’s polarity was reversed (repelling), was processed as outlined above at those
pixel locations which had attracted DNA before reversing polarity. In this manner, an
estimate of how many DNA molecules were repelled from areas having non-background
concentrations immediately surrounding the lance could be made. Figure 3.13 shows the
pixels included in the estimation of the number of DNA molecules repelled from the lance.

36

3.6

Results
The DNA attraction and repulsion experiments were performed according to the

outlined protocols. In all cases the reported concentrations are only estimates developed
according to the assumptions stated in Section 3.5.2, and should not be considered precise,
absolute measurements of DNA concentration.

3.6.1

DNA Attraction Experiments
The DNA attraction experiments were carried out using two identical lances, Device

1 and Device 2, on the same MEMS die. Figure 3.10 shows the concentration maps of
Device 1’s positively charged lance after incubating in DAPI-stained DNA solution for
10 seconds, 30 seconds, and 2 minutes 48 seconds. The histograms for both the full images
and the reduced images are given to the right of the concentration maps. The estimated
mass and number of DNA molecules within the bounding box, with concentrations above
background levels, are given in Table 3.1.
Device 2’s positively charged lance was allowed to incubate under similar conditions to Device 1 for a total of 5 minutes 46 seconds. A Concentration map and histograms
for Device 2 are given in Figure 3.11, and the estimated mass and number of attracted DNA
molecules are given in Table 3.1.

3.6.2

DNA Repulsion Experiments
To simulate an actual attraction-repulsion cycle of the lance, DNA repulsion ex-

periments were performed on Device 2 immediately after completing the DNA attraction

Table 3.1: Estimated number of attracted DNA molecules in Figures 3.10 and 3.11.
Device
1
1
1
2

Attraction Time
0 minutes 10 seconds
0 minutes 30 seconds
2 minutes 48 seconds
5 minutes 46 seconds

Mass Attracted
1.92 × 10−6 ng
4.66 × 10−6 ng
6.18 × 10−6 ng
1.24 × 10−4 ng
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DNA Molecules Attracted
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Figure 3.10: Concentration maps and histograms of Device 1’s positively charged lance
after incubating in DAPI stained DNA solution for 10 seconds, 30 seconds, and 2 minutes
48 seconds. NOTE: This image is best viewed in color.
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Figure 3.11: Concentration map and histograms of Device 2’s positively charged lance after
incubating in DAPI stained DNA solution for 5 minutes 46 seconds. NOTE: This image is
best viewed in color.
experiment presented in Figure 3.11. Figure 3.12 shows a concentration map of 58 seconds
before reversing polarity, and a concentration map generated from a six second exposure
started at the moment the polarity of the lance was reversed. During the exposure, total
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Figure 3.12: Concentration maps and histograms of DNA repulsion experiments showing
Device 2’s positively charged lance before its polarity was reversed (top) and as its polarity
was reversed (bottom). The net number and percentage of DNA molecules repelled from
the lance are given in Table 3.2. NOTE: This image is best viewed in color.

amount of DNA concentrated around the lance decreased by approximately 17.6%, corresponding to a net change of over 6200 individual DNA molecules. The total mass and
number of DNA molecules associated with the lance before and after reversing polarity are
given in Table 3.2.
The location and concentrations of the pixels used to estimate the DNA associated
with the lance before and after reversing polarity are shown in Figure 3.13.

Table 3.2: Estimated mass, number and fraction of DNA molecules repelled from
Device 2’s lance as shown in Figures 3.12 and 3.13.
Mass Attracted
58 seconds before repelling 1.81 × 10−4 ng
0 – 6 seconds after repelling 1.49 × 10−4 ng
Net Change 3.18 × 10−4 ng
Percentage Change
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Figure 3.13: Concentration maps of Device 2’s lance before (left) and while (right) repelling DNA showing only those pixels used in estimating the amount of DNA repelled
from the lance (those with attracted DNA during before reversing polarity). A comparison
of the images graphically shows where the DNA was repelled from the surface of the lance.

3.7

Discussion of Results
The concentration maps and histograms in Figure 3.10 show that the total concen-

tration values (Ctotal ) decrease over time, but the calculations outlined in Equations 3.7 and
3.8 indicated the quantity of attracted DNA increases with time. This seemingly contradictory result can be explained by examining the histograms in Figure 3.10, and on further
analysis, is consistent with the interplay of diffusion and localized electrostatic forces on
DNA near the lance.
With increasing time, the distribution of concentrations shifted increasingly to the
left as background DNA, originally placed directly over the device, diffused away from
the device into the bulk saline solution. Over time, diffusion would randomly (and approximately evenly) distribute the dissolved DNA throughout the saline solution, as occurs
with the background DNA. To develop and maintain regions of concentrated DNA in the
presence of diffusion gradients an attractive force must be applied to those molecules.
The electrostatic force exerted by the positively charge lance on DNA particles near
its surface acts in opposition to the diffusion gradients in the solution. With increasing
time, the number of pixels above the background concentration increased, as indicated
by the height of the portion of the histograms labeled “Attracted DNA”. These outlying
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concentrations physically represent DNA molecules that had been concentrated around the
lance. Allowing DNA attraction to continue for longer periods of time produced larger,
more concentrated regions of attracted DNA such as those shown in Figure 3.11.
To be practically useful as in nanoinjector, the lance must be able to deliver sufficient quantities of DNA to the interior of the cell to result in successful genetic integration.
Work on the optimization of the microinjection of mouse embryos showed integration of
the injected DNA was highest when approximately 400-500 copies of the transgene were
injected [2]. The estimates of the number of DNA molecules attracted to the MEMS lance’s
surface given in Table 3.1 suggest that an attraction time between 10-30 seconds may be
sufficient to attract enough DNA molecules to transfect a cell.
Also, a comparison of the “Attracted DNA” portion of the histograms for the full
images and the reduced images in Figures 3.10–3.12 shows that all, or almost all pixels
with concentrations greater than the background distribution are within the area directly
surrounding the lance (the region indicated by the red bounding box). Additionally, as
the region of highest charge density, the tip of the lance had the areas of greatest DNA
concentration, which is also favorable for performing injections.
To decrease the possibility of cell trauma and to decrease the time required to perform an injection, the lance must also quickly repel the DNA attracted to its surface. As
shown in Figures 3.12 and 3.13 and Table 3.2, the lance repelled over 6200 DNA molecules
within the 6 seconds required to acquire the image. This quantity of DNA is more than the
400-500 copies required to efficiently transfect a mouse embryo.
During nanoinjector operation, the DNA attraction and DNA repulsion steps would
be repeated cyclicly for each embryo. Based on the results presented above, the total cycle
time (time to attract + time to repel) would be approximately 30-40 seconds.

3.8

Conclusion
A pumpless, polysilicon MEMS nanoinjection lance was fabricated using the poly-

MUMPS process. The MEMS lance successfully attracted and repelled measurable and
potentially useful amounts of DAPI stained DNA in 0.9% saline solution without causing
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electrolysis. Sufficient amounts of DNA to transfect a cell were attracted to the lance within
30 seconds.
DNA repulsion experiments demonstrated that the MEMS lance can repel useful
amounts of DNA in six seconds. Though only one successfully injected molecule of DNA
is required to alter the genome of a cell, greater amounts of injected DNA increase the
probability the cell will take up the foreign genetic material. Approximately 6200 DNA
molecules were repelled during the first six seconds of repulsion, suggesting that a properly
placed MEMS lance will have a high probability of successfully delivering the foreign
genetic material.
Beyond the attraction and repulsion of DNA, other macromolecules with a net
charge, or a net charged character, could be attracted and repelled from the surface of a
MEMS lance. Such molecules could include RNA, certain proteins, or synthetic macromolecules (pharmaceuticals).
The pumpless MEMS lance represents an important and significant step in the development of a self-contained, automated, MEMS-based nanoinjector. Having demonstrated the MEMS lance’s functionality as an individual device, work has commenced on
transfecting mouse egg cells using the MEMS lance.
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Chapter 4
Microinjections Performed with the Nanoinjector1

4.1

Abstract
Microinjection has been an essential tool for creating transgenic model animals

for almost 30 years. However, traditional microinjection methods typically suffer from
low overall success rates. We have developed a novel, pumpless microelectromechanical
system (MEMS) microinjector, termed a “nanoinjector” to distinguish it from traditional
microinjectors. Rather than using pumps to force liquid through a capillary tube and into
a constrained cell, the nanoinjector uses static electric charges to attract and repel DNA
from the surface of a solid lance. To constrain a cell during injection, the nanoinjector
employs a pair of on-chip grasping mechanisms, though a holding pipette may also be
employed. Initial testing on mouse zygotes indicates the nanoinjector does not significantly
decrease the viability of injected cells, and that up to 90% of injected embryos not only
survive, but express the injected transgene during early embryonic development. This selfcontained, efficient microinjection system has the potential to greatly increase the efficiency
and availability of methods for creating transgenic model animals.

4.2

Introduction
Microinjection has been an essential tool for the creation of transgenic model or-

ganisms since the first demonstration of embryonic microinjection in 1980 [1]. In the early
work on microinjection of mouse zygotes, the overall success rate, defined as the por1 This

chapter consists of a journal paper in preparation co-authored by Quentin T. Aten, Sandra H. Burnett, Brian D. Jensen, and Larry L. Howell. Once larger data sets have been collected, and a ubiquitously
expressing mouse has been generated, this article will be submitted to a peer-reviewed journal for publication.
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tion of microinjected embryos which develop into transgenic individuals, was as low as
1% [1, 37], and as high as 6% [2] under optimized conditions. Since that time, the fundamental microinjection process - the use of a hollow needle to force a DNA containing
solution into a portion of the cell - has not changed. Consequently, the overall success rate
for microinjection has remained essentially unchanged [3].
Recent work on improving microinjection focused on either improving the speed
and accuracy of the microinjection manipulations or on improving the microinjection needle itself. The use of robotic manipulation assistance was shown to increase the rate at
which an operator can perform microinjection [6, 7]; while force-feedback was shown to
increase the accuracy of the microinjection process [8]. Semiconductor fabrication techniques have been used to make finer, more consistent microinjection needles [7, 9]. All of
these advances, however, are improvements to the syringe and pump design paradigm, and
consequently, the reported success rates were similar or identical to standard microinjection [6–8].
The constant nature of microinjection success rates in spite of these advancements
in microinjection technology suggests that the fundamental concept of microinjection may
need to be changed before significant improvements in efficiency are achieved. The microelectromechanical system (MEMS) microinjector (nanoinjector) presented in this paper differs from traditional microinjectors in four significant aspects. First, the nanoinjector needle is a solid body, more properly referred to as a “lance,” employing electrostatic
charges to attract and repel DNA at its surface. Second, the nanoinjector’s lance is significantly smaller than hollow glass capillary needles. Third, the operation of the nanoinjector
is reduced to a 2-D manipulation environment. Fourth,
First, the nanoinjector’s lance is a solid body employing electrostatic charges to
attract and repel DNA at its surface. Because of its net negative character [30], DNA is
manipulated as if it were a negatively charged particle in both macro [31, 32] and microscale [33, 34] DNA analysis techniques. Applying a positive charge to the nanoinjector’s
lance causes DNA dissolved in the micro injection media to accumulate on the lance’s surface, while a negative charge repels DNA from the lance’s surface [17] once the lance has
pierced the cell. Consequently, no measurable volumes of extracellular liquid are forced
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into the cell. Only exogenous DNA and small amounts of other negatively charged components of the incubation media are repelled from the lance’s surface and into the cell. Fourth,
the nanoinjector is a nearly self-contained device.
Second, the nanoinjector’s lance is significantly smaller than hollow glass capillary
needles. The lance is 150 µm long overall, 2.0 µm thick, and tapers from maximum
width of 11 µm at an angle of 10◦ to a minimum width of approximately 150 nm. The
minimum and maximum cross sectional areas of the usable portion of the lance (the first
50 µm from the tip) are 0.30 µm2 and 17.80 µm2 respectively. In comparison, a well-made
glass capillary needle has an approximate minimum and maximum cross sectional area of
0.79 µm2 and 114 µm2 [38].
Third, the operation of the nanoinjector is reduced to a 2-D manipulation environment, especially for cytoplasmic microinjection. The nanoinjector’s lance remains parallel
to the die substrate at a fixed height equal to the target cell’s radius (50 µm in the case of
mouse zygotes) during injections. Given the lance’s fixed height (z-direction), the cell only
needs to be placed on the surface of the die substrate (the x-y plane) such that the lance
enters the cell in a favorable orientation.
Fourth, the nanoinjector is a nearly self-contained device requiring only an external voltage source and three linear mechanical inputs in the form of manual microprobes.
Research is ongoing to develop a linear actuator capable of operating in an aqueous environment. Given such an actuator, the nanoinjector could be automated, enabling high
volume microinjection of embryos.
Initial testing suggests that the nanoinjector’s embryo survival and transfection efficiencies are significantly higher than traditional methods.

4.2.1

Device Description
The nanoinjector consists of the three independently actuated mechanisms shown

in Figures 4.1 and 4.2. The three mechanisms each require a linear mechanical input
from tungsten microprobes (Cascade Microtech) at their respective slider links to achieve
their motion. The entire device is fabricated from only two structural layers of phosphorous doped, polycrystalline silicon using the PolyMUMPs fabrication service (MEMSCAP
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Figure 4.1: A labeled scanning electron micrograph of the nanoinjector showing the two
constraining mechanisms, the lance mechanism, and components of each.

Inc.) [19]. Two identical lamina-emergent [16], parallel-guiding, six-bar mechanisms [23]
grounded to the die substrate constrain the cell during microinjection. The constraining
arms are designed to grasp 100 µm zona-enclosed fertilized mouse egg cells approximately
70 µm above the die substrate (20 µm above the cell’s midline). Alternately, a glass holding pipette can also be used to constrain the cell at the proper location on the die surface
during microinjection.
The lance mechanism is also a lamina-emergent, parallel guiding, six-bar mechanism. However, it is grounded to a compliant parallel-guiding stage rather than the die
substrate. The lance mechanism’s compliant stage allows the six-bar to reach its full outof-plane height of 50 µm above the substrate (at the midline of a zona enclosed mouse
zygote), then translate 50 µm toward the constrained cell with a constant height and angle.
This two-stage motion helps prevent tearing of the zona pellucida and cell membrane by
ensuring that the mechanism bearing the lance reaches its full height away from the cell and
that the lance pierces the cellular membranes nearly normal to the membranes’ surfaces.
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Figure 4.2: A kinematic and electrical schematic representation of the nanoinjector

The kinematic link carrying the lance is electrically connected to two fixed, goldplated bond pads via two polysilicon serpentine flexures. The highly folded flexures provide an adequate electrical connection, while contributing minimal mechanical resistance
to the device’s motion. The lance mechanism (bond pads, the flexures, and lance) and the
die’s monosilicon substrate form a 230 pF capacitor. Recent work has demonstrated the
ability to electrostatically attract and repel DNA to and from the lance. To attract DNA, the
lance is positively charged by connecting it to the positive terminal of an off-chip 1.5 VDC
source, while the voltage source’s negative terminal is connected to the die substrate as
shown in Figure 4.2. DNA can be repelled from the lance’s surface by reversing the polarity of the voltage source. [17]

4.3
4.3.1

Methods
Cell Culture and Device Preparation
The mouse zygotes injected in this work were harvested from super ovulated CD-1

females 0.5 dpc. The cumulus mass was removed from ampulla, and cumulus cells were
removed from the zygotes using hyaluronidase at 300 units/ml (Sigma-Aldrich, St. Louis,
MO). The zygotes were cultured in silicone oil covered microdrops of BMOC-3 media at
37◦ and 5% CO2 . Injections were performed in a modified HEPES buffer (M2 media).
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For this study, we chose to use DsRed1 encoding red fluorescent protein (RFP) with
a human cytomegalovirus (CMV) promoter as the reporter transgene [39]. The RFP transgene was obtained by digesting pDsRed1-N1 plasmid (Clontech, Mountain View, CA) with
Afl II and Nsi I (New England Biolabs, Ipswich, MA) followed by agarose gel separation to
isolate the 1599 bp linear strand containing the CMV promoter, DsRed1 gene, and SV 40
poly-A signal. Gel extraction was performed by column chromatography (QIAquick Gel
Extraction Kit, Qiagen, Valencia, CA).
The injections were preformed using a freshly released nanoinjector. The release
process removes a protective photoresist layer, and the sacrificial layers of SiO2 encasing
the device. The release consists of a series of acetone, isopropyl alcohol, deionized water,
and 49% hydrofluoric acid [19] washes, which also sterilizes the device. If the device was
not used immediately after release, it was sterilized by ultra violet irradiation just prior
to use. After completing the release, the die containing the nanoinjector was adhesively
bonded to a 44 pin cavity-type integrated circuit (IC) package (Spectrum Semiconductor,
San Jose, CA). Then, two gold wires were ultrasonically bonded to the nanoinjector’s bond
pads and one of the package’s pins. A similar connection was made between one of the
package pins, and a bond pad connected to the die substrate. The entire package was then
placed in a custom fabricated circuit board providing electrical connections from terminal
blocks to the IC package.

4.3.2

Performing Microinjections
Using the IC package as a dish, 400 to 500 µl of M2 media warmed to 37◦ at 5%

CO2 was placed over the die, giving a total depth of 2 mm. The three microprobes actuating
the device were then lowered into position. During microinjections, cells were moved to
and from the die using a mouth pipette, as is commonly done in embryo culture. As shown
in Figure 4.3, once on the die, the cells were placed into the nanoinjector using a glass
capillary mouth pipette attached to the same type of micromanipulator used to actuate the
device.
To attract DNA, the nanoinjector and the die substrate were connected to the positive and negative terminals of a 1.5 VDC source via the custom fabricated circuit board.
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Figure 4.3: An optical micrograph of the nanoinjector in use. The two constraining mechanisms and the lance mechanisms are each being actuated by tungsten-tipped microprobes.
At left, a mouse zygote is being delivered to the device by a glass pipette attached to a
micromanipulator.

Prior to each injection, 45 to 50 ng of purified DNA suspended in tris-buffer was placed
into the media above the positively charged nanoinjector lance. The device then incubated
for two minutes to allow DNA to accumulate on the lance’s surface. Approximately one
minute after beginning DNA attraction, a zygote was placed in the center of the device and
grasped by the two constraining arms as shown in Figure 4.4. Alternatively, the cell can be
held in place by the same micromanipulator pipette used to position the cell.
Once two minutes of DNA attraction elapsed, and with the cell constrained in front
of the lance mechanism, the lance mechanism was actuated and raised to its full height.
The lance mechanism was actuated further, advancing it linearly toward the cell, until the
tip of the lance pierced both the zona pellucida and the cell membrane. With the positively
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(a) Nanoinjector constraining a latex sphere

(b) Nanoinjector constraining a mouse zygote

Figure 4.4: Microscopy images showing how an embryo is constrained during microinjection. Image (a) shows a scanning electron micrograph of the nanoinjector constraining a
100 µm diameter latex sphere as it would a mouse zygote of the same size. Image (b) is
an optical micrograph of the nanoinjector constraining a mouse zygote (≈ 0.5 dpc) during
a microinjection.

charged lance tip inside the cell membrane, the polarity of the voltage supply was reversed
(e.g. the lance mechanism was connected to the voltage supply’s negative terminal, and
the substrate was connected to the die substrate). Previous experiments showed that the
negatively charged lance repels measurable amounts of DNA from its surface in six seconds
or less [17], allowing the lance to be retracted from the cell only seconds after reversing its
polarity.
The injected zygotes were transferred back into cell culture for 24 hours. Beginning
24 hours post-injection, two sets of data were obtained from the cultured embryos: the
number of viable embryos post-injection, and the number of cells expressing the injected
transgene. The viability of both negative control (untreated) and injected embryos in three
identical experimental runs were determined by observing the embryos’ morphology 24
hours post-injection (the approximate time of transfer to pseudo-pregnant females). The
number of expressing cells in the experimental Run 3 was determined by observing the
expression of RFP using a fluorescent microscope fitted with a rhodamine red filter. The
cells were imaged every 12 hours from 24 hours post-injection to 108 hours post-injection.
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4.4

Results
Table 4.1 contains the observed number of viable control and injected embryos in

three identical experiments. The viability rates of the control cells and the injected cells,
defined as the percentage of viable cells, are not significantly different (p-value = 0.45).
Table 4.2 contains the observed number of expressing embryos relative to the total number of injected embryos in experimental Run 3 from Table 4.1. The percentage of
expressing cells increased from 20% 24 hours post-injection to 90% expression 108 hours
post-injection. However, the morphology of one of the ten injected cells indicated it died
approximately 24 hours post-injection. Figure 4.5 shows white light and filtered, fluorescent images of the injected embryos 108 hours post-injection.

Table 4.1: The number of viable control (untreated) and MEMS microinjected embryos
24 hours post-injection. The number of viable cells was determined by observation
of the embryos’ morphology. The data is given as the viable cells / total cells,
with the percentage of viable cells given in parentheses.
Run
1
2
3

Control Viability
45 / 49 (91.8%)
14 / 14 (100%)
10 / 11 (90.9%)

Injected Embryo Viability
13 / 15 (86.7%)
24 / 25 (96.0%)
9 / 10 (90.0%)

Table 4.2: The number of cells exhibiting whole-cell expression of an injected red
fluorescent protein (RFP) transgene 24 to 108 hours post-injection in
experimental Run 3 in Table 4.1.
Hours
Expressing
Post-injection Embryos
24
2 / 10
36
2 / 10
48
3 / 10
60
4 / 10
72
4 / 10
84
7 / 10
96
7 / 10
108
9 / 10
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Expression
Percentage
20%
20%
30%
40%
40%
70%
70%
90%

Figure 4.5: White light, and rhodamine red filtered fluorescent images of an untreated control embryo and an embryo transfected with the dsRed1 (RFP) transgene using the nanoinjector 39 hours post-injection (≈ 1.5 dpc). The transfected embryo is exhibiting whole-cell
cytoplasmic expression of RFP, while the control cell exhibits no auto-fluorescence under
these conditions. The embryos are at the early two-cell stage, as indicated by the cleavage
line visible in the white light images. NOTE: This image best viewed in color.

4.5

Discussion
The viability data, though preliminary, show that the nanoinjector does not sig-

nificantly decrease the viability of the injected embryos. We believe that the lance’s small
cross-sectional area and its electrostatic repulsion of DNA cause a minimal amount of physical trauma to the embryos. Specifically, not introducing measurable volumes of microinjection buffer into the cell, as is standard in traditional microinjections, likely decreases the
trauma to the cell. Also, the electric field generated by the electrostatic lance apparently
has no detrimental effect on embryo viability.
The initial expression data suggest that the nanoinjector has a high success rate, as
defined by the number of embryos which express the injected DNA early in the embryonic development. The 90% success rate achieved in Run 3 is very encouraging, especially considering the low transcriptional activity of embryos in the pre-morula stages of
development [40]. More replicate experiments will be performed to statistically validate
this success rate and determine the rate of transgene integration into the host organism’s
genome.
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Because the nanoinjector operates on the principle of electrostatic attraction and
repulsion of DNA, it may be possible that the nanoinjector introduces DNA into the cell
both by mechanical or physical means (puncturing the cells with DNA on the lance tip) and
by highly localized electroporation. The electric field at the tip of the nanoinjector’s lance
is estimated to be approximately 300 V/cm, comparable to the electric field in modern
electroporation systems [41]. Unlike electroporation systems, however, the electric field
experienced by the cell is very localized, with the majority of the field extending from
the tip of the lance to the chip substrate. Additionally, the leakage current during the
attraction and repulsion of DNA is approximately 20 µA, the majority of which will enter
the media at the much more conductive gold bond pads, rather than the polysilicon lance.
By both physically puncturing the cellular membranes and by possibly causing localized
electroporation, DNA is effectively introduced and expressed by microinjected embryos.
The microinjection manipulations are also greatly simplified by the planar nature
of the nanoinjector. Because the lance operates at a fixed height and angle, optimized for
the type of cell to be manipulated, the actual manipulation of the cell is reduced to a series
of pick-and-place operations in the two dimensional space of the MEMS die. Because of
the simple manipulation steps, the operator was able to perform the physical manipulations
involved in using the nanoinjector in only 30-40 seconds after only a few hours of practice.
Currently, we are developing a MEMS scale actuator capable of operating while
submerged in cell culture media. With the addition of such an on-chip actuator, the nanoinjector could be fully automated, with a simple robotic manipulator (similar to those used to
automate the testing of integrated circuits) performing the pick and place operations with
the zygotes. Thus, all the microinjection tasks (excluding the pick and place operations)
would be performed by a single, self contained, chip level system.
The nanoinjector’s high viability and expression rates among injected embryos suggest the nanoinjector will have a significantly higher overall success rate (the ratio of expressing transgenic animals to number of embryos injected) than current microinjection
methods. Combined with the relative ease of operating the device in the 2-D plane of the
chip, and considering the real potential for automation, the nanoinjector could enable truly
high throughput generation of transgenic embryos. Finally, since the nanoinjector is pro53

duced using standard semiconductor fabrication techniques, the device could be produced
very inexpensively and in large volumes. An inexpensive, effective, and fast microinjection
system could make transgenic model organisms available to a wider number of researchers,
and help increase the pace of transgenic research.
More broadly, the concept of an electrostatic nanoinjector could find applications
beyond the insertion of a single transgene. In its current embodiment, the nanoinjector
could be used to efficiently study of embryo lethal genetic modifications. Also, because
no measurable volumes of extraneous liquid are introduced into the cell, the electrostatic
injection method could simultaneously deliver multiple transgenes without causing additionally physical trauma to the cell, where as the traditional microinjection of high concentrations or volumes of DNA cause high rates of embryo death. In much the same manner,
other charged membrane-impermeable macromolecules could be also be injected, either
by themselves, or in combination with DNA. Ultimately, the electrostatic lance could find
application in therapeutic procedures such as the transfection of bone marrow cells for use
in gene therapy.
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Chapter 5
Conclusions

The nanoinjector has led to contributions in both engineering and molecular biology. More importantly, current and future work on the nanoinjector has the potential to
enable the device to transition from a research topic in itself, to a viable research tool aiding
in the study of genetics, genomics, immunology, developmental biology, and other fields.

5.1

Contributions to Engineering
The nanoinjector has shown the great potential of using bio-MEMS devices to phys-

ically manipulate cells. Unlike many other MEMS cell manipulators, which require more
complex, or even exotic fabrication processes, the nanoinjector is fabricated using the relatively simple polyMUMPs prototyping service. Early stages of testing established certain
operational limitations for such devices operating in physiological solutions. Specifically,
voltages greater than 1.5 VDC cause electrolysis of the water surrounding the nanoinjector,
damaging devices, especially those coated in gold.
Though only 3.5 µm tall when fabricated, the nanoinjector’s lamina-emergent design enables the constraining and lance mechanisms to achieve in and out-of-plane displacements sufficient to position, constrain, and inject a 100 µm diameter mouse zygote.
Additionally, the solid nanoinjector lance demonstrates it is possible to produce a solid
lance body with a cross section much smaller than even the finest hollow microinjection
needles using standard MEMS fabrication technology. The lance’s diminutive cross section
is likely a key factor in the high rates of cell viability seen in the microinjections thus far.
Performing the cellular manipulations in the plane of the die surface reduces the
manipulation environment to only two dimensions. Consequently the complexity of the
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manipulations involved in microinjection are greatly reduced, and can be completed by
three linear actuators. Only a few hours training and practice are required to operate the
nanoinjector in its two-dimensional environment, which is a significant improvement of the
months typically spent learning how to use a traditional nanoinjector.
The most novel mechanical aspect of the nanoinjector is the lance mechanism’s
two stage sequential motion. By attaching the lamina-emergent, six-bar mechanism to a
fully compliant, in-plane, parallel-guiding mechanism, the lance can reach its full heigh
before translating toward the cell. Thus, the lance follows a linear path with constant angle
and elevation into and out of the cell, thus preventing damage to the cell’s membranes.
Additionally, both the out-of-plane motion and the in-plane translation toward the cell can
be achieved using a single actuator, maintaining the simplicity of the device.
Finally, the nanoinjector reduces both the size and the complexity of microinjection
systems. By using kinematic mechanisms and electrostatic charges rather than capillaries
and pumps, the nanoinjector can perform all of the physical manipulation tasks of a modern
microinjector, but with a much smaller, simpler system.

5.2

Contributions to Molecular Biology
Likely the greatest difference between the nanoinjector and modern microinjectors

is the use of electrostatic attraction and repulsion of DNA rather than macroscale pumps.
Initial testing showed that the nanoinjector can attract, and quickly repel useful amounts of
DNA from the lance’s tip. Electric fields have been used for decades to move DNA from
one location to another, however, the nanoinjector is the first device to use electrostatic
charges to physically aggregate and introduce DNA into a cell. The electrostatic lance has
the specific advantage of preventing cell trauma (especially ruptured membranes) by not
introducing extraneous fluid along with the genetic material of interest.
The combination of the lance’s small size, the lance mechanism’s pure linear motion, and the absence of extraneous injected fluid likely contribute to the dramatic increases
in cell viability over traditional microinjection methods. While traditional microinjections
often result in high (greater than 50%) embryo mortality rates, the nanoinjector does not
significantly decrease viability of injected embryos. The high rate of viability among very
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delicate embryonic cells also implies that-short term exposure to heavily doped polysilicon
and silicon nitride is biocompatible.
Finally, the nanoinjector has performed a useful molecular and microbiological operation on mouse embryos. Initial testing has shown that the post-injection rates of transgene expression are as high as 90% for the nanoinjector. In addition to demonstrating the
functionality and usefulness of the nanoinjector, these successful injections have raised the
possibility that the nanoinjector may operate on a hybrid physical and electrical (electroporation) means for introducing DNA into cells.

5.3

Future Work and Anticipated Contributions
Future work on the nanoinjector will focus on making mechanical improvements to

the device, and on expanding the experimentation done in-vitro to in-vivo studies.
Mechanically, the rigid link’s scissor hinges present a major physical weakness in
the out-of-plane direction. A fully compliant embodiment of the lamina-emergent sixbar mechanism could potentially make the device’s out-of-plane motion more stable and
predictable. Additionally, a fully compliant embodiment may also enable the use of simpler
single layer processes for the nanoinjector.
The greatest mechanical potential of the device is the possibility of actuating the
system with an on-chip MEMS device. Thus, with the exception of the ”pick and place”
pipette and a voltage source, the nanoinjector could be a fully automated, self-contained
microinjection system. Potential underwater actuators include steam actuators and low
voltage thermal actuators.
Though the RFP expressing embryos conclusively indicated the nanoinjector introduced foreign DNA into the embryos, they did not definitively indicate genomic integration of the injected DNA or that the injection process is developmentally neutrality, both
of which are required for stable germ line transmission of transgenes. To conclusively determine if the nanoinjector can be used to create stable transgenic organisms, a transgenic
mouse is planned to be produced. Currently, work is underway to refine the injection parameters (cell culture composition, cell handling protocols, DNA attraction time, etc.) so
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that early stage blastocyst embryos can be implanted into surrogate mothers and raised to
term.
In a much broader sense, the desired contribution of this work is increasing the
availability of genetically or chemically modified cells and organisms. Looking beyond
the insertion of a single transgene, the electrostatic lance concept could be used to inject
siRNA, dsRNA, knock-in genes, knock-out genes, multiple transgenes, hormones, antibodies, antigens, charged membrane impermeable molecules, or combinations thereof. In the
near term, the nanoinjector or other electrostatic lance systems based on it, will likely be
used in academic research. However, a device based on the nanoinjector could be used
to perform gene therapy on tissues collected from a patient, such as bone marrow cells
in cancer patients. Thus the nanoinjector could potentially facilitate and expedite areas
of research requiring microinjection, and it could lead to novel therapeutic devices and
methods.
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Appendix A
Information on the dsRed1 Gene

The information outlined below is a summary of the key characteristics of the pdsRed1-N11 plasmid (Clontech, Mountain View) vector containing the CMV-RFP gene
used in the microinjections in Chapter 4. For full information, including the gene sequence,
the plasmid’s manufacturer should be consulted

A.1

Abbreviated Map of the p-dsRed1-N1 Plasmid

Figure A.1 graphically indicates the location of the major features on the p-dsRed1N1 Plasmid. The cytomegalovirus (CMV) promoter, red fluorescent protein gene (dsRed1),
and simian vacuolating virus 40 (SV40) poly-A signal make up the gene that was injected
into the mouse embryos in Chapter 4. The other features are used in the replication of the
plasmid in bacterial culture. Specifically, the kanamycin / neomycin resistance gene and
the herpes simplex virus (HSV) thymidine kinase (TK) poly-A signal are used to give the
transformed bacteria an antibiotic resistance, which is then used to select for transformed
bacteria.
Table A.2 gives the location of the restriction enzymes used to excise the CMVdsRed1 gene from the plasmid, as described in Appendix B.
1 Clontech

catalog number 6921-1

Table A.1: Name and location of major features on p-dsRed1-N1. The locations of each
feature are given as the number of base pairs from the first base pair in the CMV
promoter in the 3’ to 5’ direction on the coding strand.
Plasmid Feature
Cytomegalovirus (CMV) Promoter
Multiple Cloning Site
Red Fluorescent Protein Gene (dsRed1)
Simian Vacuolating Virus 40 (SV40) Poly-A Signal
Kanamycin and Neomycin Resistance Gene
Herpes Simplex Virus (HSV) TK Poly-A Signal
Plasmid Replication Origin

63

Location (Base Pairs)
1 - 589
591 - 671
672 - 1359
1511 1516 & 1540 1545;
2588 - 3382
3618 - 3623 & 3631 - 3636
3967- 4610

1

4610

Plasmid Replication Origin

CMV Promoter

3967

HSV TK Poly-A Signal

3636

pdsRed1-N1

3618

589
591 Multiple Cloning Site
671
672
dsRed1

3382

1359

Kan/Neo Reistance

1511 - 1545
SV40 Poly-A Signals

2588

Figure A.1: An annotated map of the p-dsRed1-N1 plasmid. Numerical locations given (in
base pairs) are as given in Table A.1. The graphical location of each feature is not to scale.

A.2

Notes on dsRed1 in Transgenic Mouse Embryos

The dsRed1 is a useful marker in cell culture, and can be expressed at high levels [39], and provided an effective indicator of successful microinjection in mouse embryos
in the experiments reported in Chapter 4. However, efforts to use dsRed1 in ubiquitously
expressing mice have demonstrated that dsRed1 is likely not developmentally neutral in
mice; e.g. it prevents the full development of mouse embryos carrying the gene [42]. The
RFP variant encoded by dsRed1 is tetrameric, and is known to aggregate in the cytoplasm
of expressing cells [43].
More recently, researchers have successfully created mice ubiquitously expressing
modified forms of dsRed. A modified tetrameric form of dsRed RFP with reduced aggregation called DsRed-T3 (also known as DsRed-MST) was successfully employed in
the generation of a high and ubiquitously expressing mouse [44]. Another modification
of dsRed, called dsRed2, was used to create both ubiquitously expressing, and selectively
expressing mice [45]. However, in both of these cases, a tetrameric form of dsRed was
employed, and there seem to be some unresolved issues with aggregation. A monomeric
form of dsRed (dsRed-m) dose not form aggregates, and the generation of ubiquitously
expressing mice demonstrated dsRed-m is developmentally neutral in mice [43].

Table A.2: Name and location of important restriction digest sites on p-dsRed1-N. The
location of the cut is indicated by a “k” in the sequence. The locations of each
restriction digest cut site is given as the number of base pairs from the first
base pair in the CMV promoter in the 3’ to 5’ direction.
Restriction Enzyme
Afl-II
Nsi-I

Sequence
CkTTAAG
ATGCAkT
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Cut Locations
1599
2289, 2361, 4692

The next stages of this research call for the generation of a mouse with ubiquitous expression of the injected transgene. It is recommended that future work be performed using the developmentally neutral monomeric form of dsRed, dsRed-m. A pdsRed-monomer-N1 plasmid available from Clontech2 can be processed using the same
techniques reported in Appendix B.

2 Clontech

catalog number 632465
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Appendix B
DNA Replication, Restriction Digest, and Purification Protocols

The protocols outlined below can be applied to p-dsRed1-N1, p-dsRed2-N11 and
p-dsRedm-N12 variants of the dsRed RFP encoding gene. An abbreviated plasmid map
(Table A.1 and Figure A.1), and restriction digest map (Table A.2) are given in Appendix A.
Full sequences and restriction digest maps for these plasmids are available from Clontech,
Mountain View, CA.
In of these protocols, commercially available kits were used. Rather than reiterate
the manufacturer’s protocol for each kit, the manufacturer’s name and the catalog number
for each of these kits are given. Those wishing to replicate these procedures should obtain
these kits, with their instructions, from their respective manufacturers. Similar kits from
other manufacturers can be substituted given the quality of the products are equal to or
greater than those products used in these procedures.

B.1

Replication of the p-dsRed1-N1 Plasmid

Competent (being able to take up and replicate foreign DNA) DH5α E. coli bacteria
are used to replicate the p-dsRed1-N1 plasmid. In summary, the E. coli are transformed by
heat shock, cultured in selective media, and the plasmid DNA is harvested using filtration
and column chromatography. The purity and effectiveness of the plasmid is then verified
by transforming mamilian cell culture. These process are outline below.

B.1.1

Transform E. coli by Heat Shock

1. Thaw 100 µl of DH5α E. coli, but do not warm.
2. Pipette 1 µg of plasmid into thawed bacterial culture.
3. Place on ice for 15-30 minutes
4. Heat shock bacteria in a 75◦ C water bath for exactly 75 seconds.
5. Incubate on ice for 2 minutes.
1 Clontech
2 Clontech

catalog number 632406
catalog number 632465
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6. Add 900 µl of LB broth3 , and transfer to a 5 ml culture tube.
7. Incubate in a shaker at 37◦ C for 1 hour.

B.1.2

Selectively Culture Transformed E. coli

1. Warm three selective media plates (nutrient agar with kanamycin).
2. With a loop spread one plate with each of the following volumes: 50 µl, 125 µl,
200 µl.
3. Incubate 24 hours at 37◦ C.
4. Transfer one well defined colony from the selective media into 250 ml of LB broth
with kanamycin.
5. Incubate 48 hours in a shaker at 37◦ C.

B.1.3

Plasmid Purification

The plasmid purification is performed using a QIAfilter Plasmid Midi Kit from
Qiagen (catalog number 12243 and material number 1018648). The kit uses filtration and
column chromatography to extract the plasmid. A similar filter and chromatography from
other suppliers would also be satisfactory.

B.1.4

Liposome Mediated Transfection of Mammalian Cell Culture

The extracted plasmid is tested by observing for expression of the dsRed1 gene
in transfected mammalian cell culture. The transfection is performed using a liposome
based transfection agent. Specifically, this research followed the manufacturer’s suggested
protocol for PerFectin Transfection Reagent from Glenlantis (catalog number T303007),
though other transfection agents could be used in its place.
Transfections are performed to verify the quality (expression) of the transgene before extracting the CMV-dsRed1 construct using restriction endonucleases. The cell culture
should include at least one group using the stock plasmid and at least one group using the
freshly harvested plasmid. If significant differences are observed in expression or cell viability, the harvested plasmid may be contaminated or damaged.

B.2

Restriction Digest of p-dsRed1-N1 to Isolate CMV-dsRed1 Construct.

Eukaryotic cells, especially embryonic cells, find certain bacterial portions of the
p-dsRed1-N1 plasmid toxic. Also, the circularized DNA is less likely to be incorporated
3 Sigma-Aldrich

catalog number L2542
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into a transfected cell’s genome. Therefore, only the portion of the plasmid containing the
CMV promoter, dsRed1 gene, and SV40 poly-A signal (see Appendix A) are used during
microinjections. The protocol outlined below uses two restriction endonucleases to cut out
this fragment. The DNA fragments are then separated by gel electrophoresis, and purified
by column chromatography.

B.2.1

Restriction Enzyme Digest

The restriction digest employs two concurrently acting enzymes, Afl-II and Nsi-I.
The restriction sites for these two enzymes are given in Table A.2. The exact volumes of
reagents used in the restriction enzyme reaction mixture depends on the amount (mass) and
concentration of DNA to be processed. Typically, 5.0 − 7.0 µg of DNA were used in single
reaction. Table B.1 gives the concentration or amount of each reagent required to achieve
a full digestion using enzymes and buffers from New England Bio-Labs (Afl-II catalog
number R0520S, Nsi-II catalog number R0127S).
The digestion will lead to fragments 72, 690, 1599, and 2331 base pairs in length.
The 1599 base pair fragment contains the CMV-dsRed1-SV40 poly-A construct of interest.
The restriction digest follows the steps outlined below.
1. On ice, combine the reagents in a 1.5 ml centrifuge tube in the order they are given
in the listed in Table B.1.
2. Vortex the mixtures, then centrifuge at ≈ 1000g for 5 seconds.
3. Incubate the mixture in a water bath at 37◦ for 60 minutes.
4. Incubate the mixture in a water bath at 80◦ for 20 minutes.
5. Place on ice.

Table B.1: Restriction enzyme digestion reagents and their concentrations or amounts
for the digestion of 5. − 7.0µg of DNA. The DEPC water is added until
the total volume reaches 160 µl.
Reagent
DEPC
Buffer NEB2
BSA
DNA
Nsi I
Afl II

Concentration or Amount
Adjust to give 160 µl total volume
1.0x
0.1 µg/µl
5. − 7.0µg
15.0 units/µg of DNA
15.0 units/µg of DNA
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B.2.2

Fragment Separation by Gel Electrophoresis

The goal of the fragment separation by gel electrophoresis is to isolate the 1599 base
pair fragment containing the CMV-dsRed1-SV40 poly-A construct. The general protocol
for the gel extraction process is given below.
1. Prepare a 1% low melting agarose gel with 0.1% ethidium bromide. For example, a
typical 10 well mini-gel is made using the following recipe.
• Mix 0.40 g Agarose powder (Invitrogen UltraPure Agarose: catalog number
15510-019) and 40 ml TAE buffer.
• Heat until agarose is fully dissolved.
• When cool enough to handle, add 4 µg ethidium bromide from a 1 mg/ml or
10 mg/ml solution.
• Pout into mold, and cool at 4◦ for 15-20 minutes.
2. Submerge the gel in TAE buffer.
3. Load lane 1 of the gel with a suitable DNA ladder (GeneRuler 1kb DNA Ladder,
Fermantas catalog number SM0311) mixed with 6x loading dye (6x Loading Dye,
Fermentas catalog number R0611).
4. Load lanes 2-10 with 20 mul of DNA mixed with 6x loading dye (add 32 mul of
loading dye to 160 µl of digested DNA).
5. Run the gel at 120V for 45 minutes.
6. Using ultra violet light, visualize the bands, and cut out the 1599 base pair fragment.
Do not expose the DNA to more than 60 seconds (cumulative) of UV.
7. Dispose of the ethidium bromide waste as per hazardous waste protocol.

B.2.3

Gel Extraction Protocol

The gel extraction is performed following the manufacturer’s instructions for the
QIAquick Gel Extraction Kit (Qiagen catalog number 28704). After completing the first
digestion on a newly replicated batch of plasmid, it is highly recommended to verify the
fragment’s functionality by transfecting tissue culture cells according to Section B.1.4.
Other gel extraction kits should also perform satisfactorily. Store the extracted DNA at
−20◦ C until needed.
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